


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:50:28Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12407820" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12407820</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>gmic</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Gut Microbes</journal-id><journal-id journal-id-type="iso-abbrev">Gut Microbes</journal-id><journal-id journal-id-type="pmc-domain-id">1365</journal-id><journal-id journal-id-type="pmc-domain">gmic</journal-id><journal-title-group><journal-title>Gut Microbes</journal-title></journal-title-group><issn pub-type="ppub">1949-0976</issn><issn pub-type="epub">1949-0984</issn><publisher><publisher-name>Taylor &amp; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12407820</article-id><article-id pub-id-type="pmcid-ver">PMC12407820.1</article-id><article-id pub-id-type="pmcaid">12407820</article-id><article-id pub-id-type="pmcaiid">12407820</article-id><article-id pub-id-type="pmid">40884514</article-id><article-id pub-id-type="doi">10.1080/19490976.2025.2549585</article-id><article-id pub-id-type="publisher-id">2549585</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>The emerging role of the gut microbiota in vaccination responses</article-title><alt-title alt-title-type="left-running-head">V. DECKER ET AL.</alt-title><alt-title alt-title-type="right-running-head">GUT MICROBES</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Decker</surname><given-names initials="V">V.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="an0002" ref-type="author-notes">
<sup>*</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/" vocab-term="Investigation">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/" vocab-term="Methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/" vocab-term="Visualization">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/" vocab-term="Writing &#x2013; original draft">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Qureshi</surname><given-names initials="K">K.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="an0002" ref-type="author-notes">
<sup>*</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/" vocab-term="Investigation">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/" vocab-term="Methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/" vocab-term="Visualization">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/" vocab-term="Writing &#x2013; original draft">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2637-6319</contrib-id><name name-style="western"><surname>Roberts</surname><given-names initials="L">L.</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/" vocab-term="Visualization">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3231-6950</contrib-id><name name-style="western"><surname>Powell</surname><given-names initials="N">N.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7994-5239</contrib-id><name name-style="western"><surname>Marchesi</surname><given-names initials="JR">JR.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6300-3100</contrib-id><name name-style="western"><surname>Mullish</surname><given-names initials="BH">BH.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8542-327X</contrib-id><name name-style="western"><surname>Alexander</surname><given-names initials="JL">JL.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>c</sup>
</xref><xref rid="an0001" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/" vocab-term="Methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/" vocab-term="Supervision">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><aff id="aff0001"><label>a</label><institution-wrap><institution>Division of Digestive Diseases</institution></institution-wrap>, <addr-line>Department of Metabolism- Digestion and Reproduction</addr-line>, <city>Imperial College London, London</city>, <country>UK</country></aff><aff id="aff0002"><label>b</label><institution-wrap><institution>Gastroenterology and Hepatology Imperial College NHS Healthcare Trust</institution></institution-wrap>, <city>London</city>, <country>UK</country></aff><aff id="aff0003"><label>c</label><institution-wrap><institution>St Mark&#8217;s Hospital The National Bowel Hospital and Academic Institute, IBD Unit</institution></institution-wrap>, <city>London</city>, <country>UK</country></aff></contrib-group><author-notes><corresp id="an0001">CONTACT JL. Alexander <email xlink:href="mailto:j.alexander@imperial.ac.uk">j.alexander@imperial.ac.uk</email> Division of Digestive Diseases, Imperial College London, <addr-line>St Mary&#8217;s Hospital Campus Praed Street</addr-line>, <city>London</city><postal-code>W2 1NY</postal-code>, <country>UK</country></corresp><fn id="an0002"><label>*</label><p>denotes authors that have contributed equally.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>8</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><volume>17</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">477378</issue-id><elocation-id seq="306">2549585</elocation-id><pub-history><event event-type="pmc-release"><date><day>30</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 16:25:19.050"><day>04</day><month>09</month><year>2025</year></date></event><event event-type="tagger"><event-desc>Integra</event-desc><date><day>30</day><month>8</month><year>2025</year></date></event><event event-type="final"><event-desc>Integra</event-desc><date><day>30</day><month>8</month><year>2025</year></date></event><event event-type="received"><date><day>23</day><month>5</month><year>2025</year></date></event><event event-type="revised"><date><day>08</day><month>8</month><year>2025</year></date></event><event event-type="accepted"><date><day>13</day><month>8</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Author(s). Published with license by Taylor &amp; Francis Group, LLC.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="KGMI_17_2549585.pdf"/><self-uri content-type="pdf" xlink:href="KGMI_17_2549585.pdf"/><abstract><title>ABSTRACT</title><p>The gut microbiota has emerged as a key modulator of host immune responses, and growing evidence suggests it plays a role in shaping vaccine-induced immunity. While immunization remains vital for preventing infectious diseases, inter-individual variability in vaccine responses poses a persistent challenge. Traditional factors such as age, sex, genetics, and immune status do not fully account for this variability. Recent studies highlight the gut microbiome as a potential contributor. This review examines current evidence linking the gut microbiota to vaccine responses, with a focus on vaccines against SARS-CoV-2, hepatitis B virus, and influenza. Human studies show associations between microbial composition, particularly taxa like <italic toggle="yes">Bifidobacterium adolescentis</italic>, and immunogenicity. Microbial metabolites, such as short-chain fatty acids and bile acids, influence T-cell differentiation, antibody production, and cytokine responses. Factors that alter microbiota composition, including antibiotics, diet, and prebiotic or probiotic supplementation, can impact vaccine responses, highlighting a dynamic gut-immune relationship. Experimental models further support these observations, showing diminished responses in germ-free or antibiotic-treated animals and enhanced responses following microbial-based interventions. These findings also suggest the gut microbiota may be harnessed to improve vaccine efficacy. Future research should explore the potential for microbiota-targeted strategies to optimize vaccine efficacy, particularly in immunocompromised populations.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Gut microbiome</kwd><kwd>immunity</kwd><kwd>parenteral vaccines</kwd><kwd>COVID-19</kwd><kwd>vaccine efficacy</kwd></kwd-group><support-group><funding-group><award-group><funding-source><institution-wrap><institution>Medical Research Council</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100000265</institution-id></institution-wrap></funding-source><award-id>MR/Z504002/1</award-id></award-group><funding-statement>BHM is the recipient of a Medical Research Council Clinician Scientist Fellowship (MR/Z504002/1).</funding-statement></funding-group></support-group><counts><fig-count count="2"/><table-count count="1"/><ref-count count="112"/><page-count count="1"/><word-count count="8482"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" disp-level="1" id="s0001"><label>1.</label><title>Introduction</title><p>Vaccinations are essential in the prevention and eradication of many infectious diseases. Their efficacy is exemplified by the case of measles, where there were more than 460,000 cases and 90 deaths in the UK per year before vaccination was introduced.<sup><xref rid="cit0001" ref-type="bibr">1</xref></sup> In 2023, there were 216 confirmed cases and no deaths. It is believed that since vaccines were made available globally by the World Health Organization in 1974, 154 million deaths have been prevented.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup></p><p>Both humoral and cellular immune responses are necessary for vaccine-induced immunity.<sup><xref rid="cit0003" ref-type="bibr">3</xref></sup> Vaccination stimulates the generation of cross-reactive T-cells, such as CD4<sup>+</sup> and CD8<sup>+</sup>, which enable the immune response to infections such as SARS-CoV-2, mitigating COVID-19 severity.<sup><xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0005" ref-type="bibr">5</xref></sup> T-helper (Th) 17 cells, a subset of CD4<sup>+</sup> cells, are particularly reactive against pathogens that enter the body through mucosal tissue, including most respiratory and gastrointestinal infections.<sup><xref rid="cit0006" ref-type="bibr">6</xref></sup> They recruit neutrophils and drive Th1 immunity by releasing interleukin (IL) 17 and antimicrobial peptides. T-regulatory (Treg) cells, which are more abundant in older age, are thought to diminish the immune response to vaccinations, contributing to poorer vaccine-induced immunity in the elderly.<sup><xref rid="cit0007" ref-type="bibr">7</xref></sup> B-cells produce antibodies and form memory cells, which allow the production of a rapid immune response when re-encountering an antigen.<sup><xref rid="cit0008" ref-type="bibr">8</xref></sup> The antibodies produced prevent the spread of intracellular infections and cause rapid destruction of extracellular microorganisms.</p><p>Vaccinations induce varying levels of immune response, and post-vaccination breakthrough infection rates and severity of infection vary greatly between seemingly well-matched individuals.<sup><xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0010" ref-type="bibr">10</xref></sup> It is well known that immune responses to vaccinations, commonly measured using immunoglobulin (Ig) G1 levels, may vary depending on a multitude of intrinsic and extrinsic factors. Age is a key determinant of response, which is demonstrated by higher IgG levels in infants receiving the measles vaccination at the age of six&#8201;months versus nine&#8201;months.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0012" ref-type="bibr">12</xref></sup> In general, the younger healthy adult population has higher antibody responses than the elderly, which can be observed with the influenza vaccine.<sup><xref rid="cit0013" ref-type="bibr">13</xref></sup> Another well-reported factor is sex: Females have higher antibody responses to certain vaccinations, such as Hepatitis B.<sup><xref rid="cit0014" ref-type="bibr">14</xref></sup> Other known factors for certain vaccines are genetics, such as blood group antigens, immunosuppressive therapies, like long-term steroid use or biologics in immune-mediated inflammatory disorders, and comorbidities, as with children with celiac disease.<sup><xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0016" ref-type="bibr">16</xref></sup> However, these factors do not fully account for the variability in immune response.</p><p>During infancy, the colonization of the gut by microbes is known to affect the maturation of the early immune system.<sup><xref rid="cit0017" ref-type="bibr">17</xref></sup> In adults, microbiota composition impacts adaptive and innate immune homeostasis.<sup><xref rid="cit0018" ref-type="bibr">18</xref></sup> Research has also shown that drug therapies can be affected by microbiota composition. Giving a fecal microbiota transplant (FMT) to cancer patients prior to immunotherapy is associated with a better overall prognosis.<sup><xref rid="cit0019" ref-type="bibr">19</xref></sup> Moreover, the gut microbiota produces a multitude of metabolites with immuno-modulatory functions, such as short-chain fatty acids (SCFAs), branched-chain fatty acids (BCFAs) and secondary/tertiary bile acids.<sup><xref rid="cit0020" ref-type="bibr">20</xref></sup> SCFAs influence epithelial barrier integrity, immune cell metabolism and differentiation and cytokine production (IL-10).<sup><xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0022" ref-type="bibr">22</xref></sup> Bacterially derived bile acids can directly influence host immunity, as seen in the downregulation of Th17 differentiation by 3-oxolithocholic acid and isolithocholic acid.<sup><xref rid="cit0023" ref-type="bibr">23</xref></sup> As we will discuss in this review, emerging data from animal and human studies suggest that the gut microbiome may be an important factor influencing immune responses to vaccination, especially through the production of immunomodulatory metabolites. Whilst there is an existing body of literature reviewing associations between the gut microbiome and responses to orally delivered vaccines,<sup><xref rid="cit0024" ref-type="bibr">24</xref></sup> the gut microbiota also exerts its influence on immune function distant to the gut mucosal interface. Prior reviews have outlined the emerging relationship between the human microbiome and vaccine immunogenicity, focusing particularly on early life and global health settings.<sup><xref rid="cit0025" ref-type="bibr">25</xref></sup> Additionally, others have been published focusing on COVID-19 vaccination.<sup><xref rid="cit0026" ref-type="bibr">26</xref>,<xref rid="cit0027" ref-type="bibr">27</xref></sup> In the current review, we build upon this foundation and further examine and synthesize both mechanistic and clinical data linking the gut microbiome to immune responses to multiple parenterally delivered vaccines across diverse population groups and animal models.</p></sec><sec disp-level="1" id="s0002"><label>2.</label><title>Human studies</title><sec disp-level="2" id="s0002-s2001"><label>2.1.</label><title>Overview</title><p>A number of human studies have been performed in recent years assessing the composition and function of the gut microbiota in the context of parenterally delivered vaccination. These include sampling of patients receiving COVID-19 vaccines, Bacillus Calmette-Gu&#233;rin (BCG), Tetanus Toxoid (TT), Hepatitis B (HBV), Oral Polio Vaccine (OPV), PCV13 (pneumococcal), Infanrix Hexa (Diphtheria, Tetanus, Pertussis, Polio, Hepatitis B, Haemophilus influenzae type b), Meningococcal B, Pneumococcal capsular polysaccharide (PCP) and influenza vaccines (<xref rid="t0001" ref-type="table">Table 1</xref>).<table-wrap position="float" id="t0001" orientation="landscape"><label>Table 1.</label><caption><p>Summary of key observational human studies on associations of gut microbiota with parenteral vaccine immune responses.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" align="left" span="1"/><col width="1*" align="char" char="." span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="center" span="1"/><col width="1*" align="center" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Study</th><th align="center" char="." colspan="1" rowspan="1">Date</th><th align="center" colspan="1" rowspan="1">Vaccine(s) name</th><th align="center" colspan="1" rowspan="1">Vaccine(s) type</th><th align="center" colspan="1" rowspan="1">Population</th><th align="center" colspan="1" rowspan="1">Healthy or diseased population</th><th align="center" colspan="1" rowspan="1">Location</th><th align="center" colspan="1" rowspan="1">Methods for microbiota analysis</th><th align="center" colspan="1" rowspan="1">Methods for immunogenicity analysis</th><th align="center" colspan="1" rowspan="1">Associated microbiota (taxa associations)</th></tr></thead><tbody><tr><td rowspan="2" align="left" colspan="1">Ng <italic toggle="yes">et al</italic>.<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup></td><td rowspan="2" align="char" char="." colspan="1">2022</td><td rowspan="2" align="left" colspan="1">Sinovac and BNT162b2</td><td rowspan="2" align="left" colspan="1">Sinovac: Inactivated virus vaccine<break/>BNT162b2: mRNA vaccine</td><td rowspan="2" align="center" colspan="1">37 adults (Sinovac)<break/>101 adults (BNT162b2)</td><td rowspan="2" align="center" colspan="1">Healthy</td><td rowspan="2" align="left" colspan="1">Hong Kong</td><td rowspan="2" align="left" colspan="1">Stool shotgun metagenomic sequencing</td><td rowspan="2" align="left" colspan="1">SARS-CoV-2 surrogate virus neutralization test (sVNT)<break/>Anti-SARS-CoV-2 Spike-receptor binding domain (RBD) IgG ELISA</td><td align="left" colspan="1" rowspan="1">Sinovac:<break/>&#8593; <italic toggle="yes">Bifidobacterium adolescentis</italic> associated with &#8593; neutralizing antibodies<break/>&#8593; <italic toggle="yes">Bacteroides&#8201;vulgatus, Bacteroides&#8201;thetaiotaomicron</italic> &amp; <italic toggle="yes">Ruminococcus gnavus</italic> associated with &#8595; neutralizing antibodies</td></tr><tr><td align="left" colspan="1" rowspan="1">BNT162b2:<break/>&#8593; <italic toggle="yes">Bifidobacterium adolescentis</italic> associated with &#8593; neutralizing antibodies<break/>&#8593; <italic toggle="yes">Eubacterium rectale, Roseburia faecis</italic> &amp; two Bacteroides species (<italic toggle="yes">Bacteroides thetaiotaomicron</italic> &amp; <italic toggle="yes">Bacteroides</italic> sp OM05&#8211;12) associated with &#8593; neutralizing antibodies</td></tr><tr><td align="left" colspan="1" rowspan="1">Jia <italic toggle="yes">et al</italic>.<sup><xref rid="cit0029" ref-type="bibr">29</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2022</td><td align="left" colspan="1" rowspan="1">BBIBP-CorV vaccine</td><td align="left" colspan="1" rowspan="1">Inactivated virus vaccine</td><td align="center" colspan="1" rowspan="1">95 adults</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">China</td><td align="left" colspan="1" rowspan="1">16S rRNA gene sequencing</td><td align="left" colspan="1" rowspan="1">SARS-CoV-2 sVNT<break/>Anti-SARS-CoV-2 Spike-receptor binding domain (RBD) IgG ELISA</td><td align="left" colspan="1" rowspan="1">&#8593; Bacteroides &amp; Parabacteroides associated with &#8593; IgG</td></tr><tr><td align="left" colspan="1" rowspan="1">Han <italic toggle="yes">et al</italic>.<sup><xref rid="cit0030" ref-type="bibr">30</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2022</td><td align="left" colspan="1" rowspan="1">Sinovac</td><td align="left" colspan="1" rowspan="1">Inactivated virus vaccine</td><td align="center" colspan="1" rowspan="1">30 adults</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">China</td><td align="left" colspan="1" rowspan="1">Stool shotgun metagenomic sequencing</td><td align="left" colspan="1" rowspan="1">SARS-CoV-2 sVNT<break/>Anti-SARS-CoV-2 Spike-receptor binding domain (RBD) IgG ELISA</td><td align="left" colspan="1" rowspan="1">&#8593; <italic toggle="yes">Clostridium&#8201;leptum, Lactobacillus ruminis</italic> &amp; <italic toggle="yes">Ruminococcus&#8201;toques</italic> correlated with &#8593; IgG/IgM<break/>&#8593; <italic toggle="yes">Segatella&#8201;copri</italic> correlated with &#8595; IgG</td></tr><tr><td align="left" colspan="1" rowspan="1">Tang <italic toggle="yes">et al</italic>.<sup><xref rid="cit0031" ref-type="bibr">31</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2022</td><td align="left" colspan="1" rowspan="1">BBIBP-CorV vaccine</td><td align="left" colspan="1" rowspan="1">Inactivated virus vaccine</td><td align="center" colspan="1" rowspan="1">207 adults</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">China</td><td align="left" colspan="1" rowspan="1">Stool shotgun metagenomic sequencing</td><td align="left" colspan="1" rowspan="1">Virus-specific IgG/IgM Chemiluminescent Immunoassay (CLIA)<break/>ACE2-RBD inhibiting antibody CLIA</td><td align="left" colspan="1" rowspan="1">&#8593; <italic toggle="yes">Collinsella aerofaciens</italic> &amp; <italic toggle="yes">Veillonella dispar</italic> associated with &#8593; ACE2-RBD inhibiting antibodies<break/>&#8593; <italic toggle="yes">Lawsonibacter asaccharolyticus</italic> correlated with &#8595; ACE2-RBD inhibiting antibodies</td></tr><tr><td align="left" colspan="1" rowspan="1">Alexander <italic toggle="yes">et al</italic>. <sup><xref rid="cit0032" ref-type="bibr">32</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2023</td><td align="left" colspan="1" rowspan="1">ChAdOx1 nCoV-19 or BNT162b2 vaccine</td><td align="left" colspan="1" rowspan="1">ChAdOx1 nCoV-19: Viral vector vaccine<break/>BNT162b2: mRNA vaccine</td><td align="center" colspan="1" rowspan="1">15 adults<break/>(ChAdOx1 nCoV-19)<break/>28 adults<break/>(BNT162b2)</td><td align="center" colspan="1" rowspan="1">Inflammatory bowel disease (IBD) patients</td><td align="left" colspan="1" rowspan="1">UK</td><td align="left" colspan="1" rowspan="1">16S rRNA gene sequencing<break/>Metabolomic profiling using 1&#8201;H NMR<break/>Bile acid profiling using UHPLC-MS</td><td align="left" colspan="1" rowspan="1">Anti-SARS-CoV-2 Spike-receptor binding domain (RBD) antibody CLIA</td><td align="left" colspan="1" rowspan="1">&#8593; <italic toggle="yes">Bilophila</italic> associated with &#8593; antibody response<break/>&#8593; Streptococcus associated with &#8595; antibody response.</td></tr><tr><td align="left" colspan="1" rowspan="1">Hirota <italic toggle="yes">et al</italic>.<sup><xref rid="cit0033" ref-type="bibr">33</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2023</td><td align="left" colspan="1" rowspan="1">BNT162b2</td><td align="left" colspan="1" rowspan="1">BNT162b2: mRNA vaccine</td><td align="center" colspan="1" rowspan="1">95 adults</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">Japan</td><td align="left" colspan="1" rowspan="1">16S rRNA gene sequencing</td><td align="left" colspan="1" rowspan="1">Anti-SARS-CoV-2 Spike IgG ELISA</td><td align="left" colspan="1" rowspan="1">No significant correlations between these taxa and vaccine-induced antibody or T cell responses after adjustments for age, sex, and stool sampling timing.</td></tr><tr><td align="left" colspan="1" rowspan="1">Daddi <italic toggle="yes">et al</italic>.<sup><xref rid="cit0034" ref-type="bibr">34</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2023</td><td align="left" colspan="1" rowspan="1">BNT162b2 and SpikeVax</td><td align="left" colspan="1" rowspan="1">BNT162b2: mRNA vaccine<break/>Spikevax: mRNA vaccine</td><td align="center" colspan="1" rowspan="1">9 adults (BNT162b2)<break/>7 adults <break/>(Spikevax)</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">16S rRNA gene Sequencing</td><td align="left" colspan="1" rowspan="1">Anti-SARS-CoV-2 Spike IgG. ELISA</td><td align="left" colspan="1" rowspan="1">&#8593; <italic toggle="yes">Bilophila (</italic>Desulfobacterota) correlated with &#8593; IgG<break/>&#8593; <italic toggle="yes">Colidextribacter, Clostridium innocuum, Lachnoclostridium, Bacteroides</italic> &amp; an unclassified <italic toggle="yes">Lachnospiraceae</italic> genus with &#8595; IgG</td></tr><tr><td rowspan="2" align="left" colspan="1">Peng <italic toggle="yes">et al</italic>.<sup><xref rid="cit0035" ref-type="bibr">35</xref></sup></td><td rowspan="2" align="char" char="." colspan="1">2023</td><td rowspan="2" align="left" colspan="1">BNT162b2 and Sinovac</td><td rowspan="2" align="left" colspan="1">BNT162b2: mRNA vaccine<break/>Sinovac: Inactivated virus vaccine</td><td rowspan="2" align="center" colspan="1">121 adults (BNT162b2)<break/>40 adults<break/> (Sinovac)</td><td rowspan="2" align="center" colspan="1">Healthy</td><td rowspan="2" align="left" colspan="1">Hong Kong</td><td rowspan="2" align="left" colspan="1">Stool shotgun metagenomic sequencing</td><td rowspan="2" align="left" colspan="1">SARS-CoV-2 sVNT</td><td align="left" colspan="1" rowspan="1">BNT162b2:<break/>&#8593; <italic toggle="yes">Bifidobacterium adolescentis, Bifidobacterium bifidum</italic>, &amp; <italic toggle="yes">Roseburia faecis</italic> associated with &#8593; neutralizing antibodies</td></tr><tr><td align="left" colspan="1" rowspan="1">Sinovac:<break/>&#8593; <italic toggle="yes">Phocaeicola dorei, Blautia massiliensis</italic>, &amp; <italic toggle="yes">Dorea formicigenerans</italic> associated with &#8593; neutralizing antibodies<break/>&#8593; <italic toggle="yes">Faecalibacterium prausnitzii</italic> associated with &#8595; neutralizing antibodies</td></tr><tr><td align="left" colspan="1" rowspan="1">Lunken <italic toggle="yes">et al</italic>.<sup><xref rid="cit0036" ref-type="bibr">36</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2023</td><td align="left" colspan="1" rowspan="1">BNT162b2</td><td align="left" colspan="1" rowspan="1">BNT162b2: mRNA vaccine</td><td align="center" colspan="1" rowspan="1">52 adults</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">Canada</td><td align="left" colspan="1" rowspan="1">16S rRNA gene Sequencing</td><td align="left" colspan="1" rowspan="1">Anti-SARS-CoV-2 Spike IgG CLIA<break/>ACE2-RBD inhibiting assay (CLIA)</td><td align="left" colspan="1" rowspan="1">&#8593; <italic toggle="yes">Bifidobacterium animalis, Bacteroides plebeius</italic> &amp; <italic toggle="yes">Bacteroides ovatus</italic> associated with &#8593; IgG avidity<break/>&#8593; <italic toggle="yes">Bifidobacterium bifidum</italic> &amp; <italic toggle="yes">Akkermansia intestini</italic> associated with &#8595; IgG avidity<break/>&#8593; <italic toggle="yes">Prevotella, Haemophilus, Veillonella</italic> &amp; <italic toggle="yes">Ruminococcus&#8201;gnavus</italic> associated with &#8593; antibody production</td></tr><tr><td align="left" colspan="1" rowspan="1">Ray <italic toggle="yes">et al</italic>.<sup><xref rid="cit0037" ref-type="bibr">37</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2023</td><td align="left" colspan="1" rowspan="1">BNT162b2</td><td align="left" colspan="1" rowspan="1">BNT162b2: mRNA vaccine</td><td align="center" colspan="1" rowspan="1">180 adults</td><td align="center" colspan="1" rowspan="1">90&#160;healthy<break/>90 people living with HIV (PLWH)</td><td align="left" colspan="1" rowspan="1">Sweden</td><td align="left" colspan="1" rowspan="1">16S rRNA gene Sequencing</td><td align="left" colspan="1" rowspan="1">Anti-SARS-CoV-2 Spike IgG CLIA<break/>CD4+ T cell assay<break/>Flow cytometry (CD4+ and CD8+ T-cell counts and HIV viral load)</td><td align="left" colspan="1" rowspan="1">&#8593; <italic toggle="yes">Bifidobacterium and Faecalibacterium</italic> associated with &#8593; IgG<break/>&#8593; <italic toggle="yes">Agathobacter, Lactobacillus, Bacteroides</italic>, &amp; <italic toggle="yes">Lachnospira</italic> correlated with &#8593; IgG and CD4+ T cells<break/>&#8593; <italic toggle="yes">Methanobrevibacter</italic>, Ruminococcaceae DTU089, <italic toggle="yes">Marvinbryantia, Cloacibacillus</italic>, &amp; <italic toggle="yes">Succinivibrio</italic> associated with &#8595; IgG</td></tr><tr><td align="left" colspan="1" rowspan="1">Seong <italic toggle="yes">et al</italic>.<sup><xref rid="cit0038" ref-type="bibr">38</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2024</td><td align="left" colspan="1" rowspan="1">BNT162b2 and ChAdOx1</td><td align="left" colspan="1" rowspan="1">BNT162b2: mRNA vaccine<break/>ChAdOx1 nCoV-19: Viral vector vaccine</td><td align="center" colspan="1" rowspan="1">23 adults (BNT162b2)*<break/>21 adults (ChAdOx1)*<break/>*all 44 received BNT162b2 booster</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">South Korea</td><td align="left" colspan="1" rowspan="1">16S rRNA gene and shotgun metagenomic sequencing</td><td align="left" colspan="1" rowspan="1">Anti-SARS-CoV-2 Spike IgG CLIA</td><td align="left" colspan="1" rowspan="1">BNT162b2:<break/>&#8593; <italic toggle="yes">Faecalibacterium prausnitzii</italic> associated with &#8593; IgG<break/>&#8593; <italic toggle="yes">Faecalibacterium prausnitzii Prevotella_uc</italic>, &amp; PAC001304_s <italic toggle="yes">(Prevotella), G. formicilis, Bacteroides dorei</italic>, and <italic toggle="yes">Anaerostipes rectalis</italic> associated with &#8593; antibody half-life<break/>ChAdOx1: &#8593; <italic toggle="yes">Escherichia coli, Alistipes, Parabacteroides</italic> &amp; <italic toggle="yes">Enterococcus</italic> associated with &#8593; antibody half-life</td></tr><tr><td align="left" colspan="1" rowspan="1">Ng <italic toggle="yes">et al</italic>.<sup><xref rid="cit0039" ref-type="bibr">39</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2025</td><td align="left" colspan="1" rowspan="1">BNT162b2</td><td align="left" colspan="1" rowspan="1">BNT162b2: mRNA vaccine</td><td align="center" colspan="1" rowspan="1">242 adults</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">Hong Kong</td><td align="left" colspan="1" rowspan="1">Shotgun <break/>metagenomic <break/>sequencing</td><td align="left" colspan="1" rowspan="1">Chemiluminescent microparticle immunoassay</td><td align="left" colspan="1" rowspan="1">&#8593; <italic toggle="yes">Ruminococcus bicirculans, Phocaeicola excrementihominis and Streptococcus salivarius</italic> associated with &#8593; neutralizing antibodies<break/>&#8593; <italic toggle="yes">Bacteroides thetaiotaomicron</italic> associated with &#8595; neutralizing antibodies</td></tr><tr><td align="left" colspan="1" rowspan="1">Huda <italic toggle="yes">et al</italic>.<sup><xref rid="cit0040" ref-type="bibr">40</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2014</td><td align="left" colspan="1" rowspan="1">BCG, TT, HBV, Oral Polio Vaccine (OPV)</td><td align="left" colspan="1" rowspan="1">BCG: Live attenuated vaccine<break/>TT: Toxoid vaccine<break/>HBV: Recombinant subunit vaccine<break/>OPV: Live attenuated vaccine</td><td align="center" colspan="1" rowspan="1">48 infants</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">Bangladesh</td><td align="left" colspan="1" rowspan="1">16S rRNA gene sequencing</td><td align="left" colspan="1" rowspan="1">Polio-specific IgA and IgG, HBV-specific IgG and TT-specific IgG Enzyme-Linked Immunosorbent Assay (ELISA)<break/>Flow cytometric assay of specific cell-mediated immune response in activated whole blood (FASCIA)</td><td align="left" colspan="1" rowspan="1">&#8593; Actinomycetota associated with &#8593; T-cell responses to BCG, OPV, and TT &amp; TT- and Purified Protein Derivative (PPD)- specific IgG<break/>&#8593; <italic toggle="yes">Enterobacteriales</italic> associated with &#8595; T-cell responses to TT &amp; PPD-specific IgG<break/><italic toggle="yes">Pseudomonadales</italic> associated with &#8595; T-cell responses to HBV, OPV, and TT<break/><italic toggle="yes">Clostridiales</italic> associated with &#8595; T-cell responses to TT</td></tr><tr><td align="left" colspan="1" rowspan="1">Huda <italic toggle="yes">et al</italic>.<sup><xref rid="cit0041" ref-type="bibr">41</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2019</td><td align="left" colspan="1" rowspan="1">BCG, TT HBV, Oral Polio Vaccine (OPV)</td><td align="left" colspan="1" rowspan="1">BCG: Live attenuated vaccine<break/>TT: Toxoid vaccine<break/>HBV: Recombinant subunit vaccine<break/>OPV: Live attenuated vaccine</td><td align="center" colspan="1" rowspan="1">291 infants</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">Bangladesh</td><td align="left" colspan="1" rowspan="1">16S rRNA gene sequencing method</td><td align="left" colspan="1" rowspan="1">Polio-specific IgA and IgG, HBV-specific IgG and TT-specific IgG ELISA<break/>FASCIA</td><td align="left" colspan="1" rowspan="1">BCG: &#8593; <italic toggle="yes">Bifidobacterium</italic> in early infancy associated with &#8593; CD4+ response at 2&#8201;years<break/>TT:<break/>&#8593; <italic toggle="yes">Bifidobacterium</italic> in early infancy associated with &#8593; CD4+ response at 15 wks, and &#8593; IgG response at 2&#8201;yrs<break/>HBV:<break/>&#8593; <italic toggle="yes">Bifidobacterium</italic> in early infancy associated with &#8593; CD4+ response at 15 wks, and &#8593; CD4+ response and IgG response at 2&#8201;yrs<break/>OPV:<break/>&#8593; <italic toggle="yes">Bifidobacterium</italic> in early infancy associated with &#8593; IgG response at 15 wks, and &#8593; IgA and IgG response at 2&#8201;yrs</td></tr><tr><td align="left" colspan="1" rowspan="1">Moroishi <italic toggle="yes">et al</italic>.<sup><xref rid="cit0042" ref-type="bibr">42</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2022</td><td align="left" colspan="1" rowspan="1">Pneumococcal capsular polysaccharide (PCP) and TT vaccines</td><td align="left" colspan="1" rowspan="1">PCP: polysaccharide vaccine<break/>TT: Toxoid vaccine</td><td align="center" colspan="1" rowspan="1">133 infants (TT)<break/>22 infants (PCP)</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">USA</td><td align="left" colspan="1" rowspan="1">16S rRNA gene sequencing</td><td align="left" colspan="1" rowspan="1">Anti-PCP Ig assay<break/>TT IgG ELISA</td><td align="left" colspan="1" rowspan="1">TT:<break/>&#8593; <italic toggle="yes">Aeriscardovia aeriphila</italic> associated with &#8595; TT IgG</td></tr><tr><td align="left" colspan="1" rowspan="1">Ryan <italic toggle="yes">et al</italic>.<sup><xref rid="cit0043" ref-type="bibr">43</xref></sup></td><td align="char" char="." colspan="1" rowspan="1">2025</td><td align="left" colspan="1" rowspan="1">PCV13, Infanrix Hexa (Diphtheria, Tetanus, Pertussis, Polio, Hepatitis<break/> B, <italic toggle="yes">Haemophilus influenzae</italic> type b) and Meningococcal B</td><td align="left" colspan="1" rowspan="1">PCV13: conjugate vaccine<break/>Diphtheria: Toxoid vaccine<break/>TT: Toxoid vaccine<break/>Pertussis: Acellular subunit vaccine<break/>Polio: Inactivated vaccine<break/>Hepatitis B: Recombinant subunit vaccine<break/><italic toggle="yes">Haemophilus influenzae</italic> type b: Conjugate vaccine<break/>Meningococcal B: Recombinant subunit vaccine</td><td align="center" colspan="1" rowspan="1">191 infants</td><td align="center" colspan="1" rowspan="1">Healthy</td><td align="left" colspan="1" rowspan="1">Australia</td><td align="left" colspan="1" rowspan="1">Shotgun metagenomic sequencing</td><td align="left" colspan="1" rowspan="1">Vaccine-specific IgG titers (ELISA)<break/>Opsonophagocytic assay (functional antibody response)<break/>Serum bactericidal assay</td><td align="left" colspan="1" rowspan="1">&#8595; <italic toggle="yes">Bifidobacterium</italic> species (<italic toggle="yes">Bifidobacterium breve, Bifidobacterium pseudocatenulatum</italic> and <italic toggle="yes">B. bifidum</italic>) at week 6 (neonatal antibiotic group) correlated with &#8595; IgG titers against PCV13 polysaccharides (esp. PPS6B) and <italic toggle="yes">Haemophilus influenzae</italic> type b and diphtheria toxoid antigens</td></tr></tbody></table></table-wrap></p><p>These studies have generally analyzed baseline microbiota using stool samples collected prior to vaccination and vaccine immunogenicity using blood samples collected after immunization to determine associations between microbiota composition and immune responses.</p><p>These studies consistently report significant associations between gut microbiota and parenteral vaccine immunogenicity, and some associations appear to be common across studies and vaccine types (<xref rid="f0001" ref-type="fig">Figure 1</xref>).<fig position="float" id="f0001" fig-type="figure" orientation="portrait"><label>Figure 1.</label><caption><p>Diagram representing microbiota-vaccine associations and antibody responses This diagram shows reported links between specific gut microbiota genera and immunogenic response for various vaccines. Genera associated with lower antibody responses are pictured in the red section, genera associated with both lower and higher antibody responses are pictured in the orange section and genera associated with higher antibody response are pictured in the green section, with the vaccines implicated in the gray section. Microbes supported by only single studies are included but displayed without connections to reduce visual complexity.</p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KGMI_A_2549585_F0001_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KGMI_A_2549585_F0001_PB.jpg"/></alternatives></fig></p></sec><sec disp-level="2" id="s0002-s2002"><label>2.2.</label><title>COVID-19 vaccines</title><p>Several studies have explored associations between the pre-vaccination gut microbiota and responses to COVID-19 vaccines. Ng <italic toggle="yes">et al</italic>. investigated the impact of microbiota composition on the immune response to Sinovac and BNT162b2, stratifying participants into high and low responders according to antibody titers.<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup> High responders of the Sinovac vaccine showed a high baseline abundance of <italic toggle="yes">Bifidobacterium adolescentis</italic> relative to low responders, and a reduction of <italic toggle="yes">Bacteroides vulgatus</italic> one month post vaccination, with the latter correlating with antibody production. Similarly, within the baseline microbiota of the BNT162b2 cohort, <italic toggle="yes">B. adolescentis</italic> was enriched in the high responders, alongside <italic toggle="yes">Eubacterium rectale</italic>, <italic toggle="yes">Roseburia faecis</italic> and two <italic toggle="yes">Bacteroides</italic> species (<italic toggle="yes">Bacteroides thetaiotaomicron</italic> and <italic toggle="yes">Bacteroides sp OM05&#8211;12)</italic>. In the BBIBP-CorV vaccine, high levels of <italic toggle="yes">Bacteroides</italic> and <italic toggle="yes">Parabacteroides</italic> in the commensal gut microbiota of human participants were also associated with increased IgG production.<sup><xref rid="cit0029" ref-type="bibr">29</xref></sup> Meanwhile, Tang <italic toggle="yes">et al</italic>. found high responders to the BBIBP-CorV vaccine exhibited a high abundance of baseline <italic toggle="yes">Collinsella aerofaciens</italic> and <italic toggle="yes">Veillonella dispar</italic> relative to low responders, both of which correlated with increased IgG production.<sup><xref rid="cit0031" ref-type="bibr">31</xref></sup> Another study examined microbiota changes to the BNT162b2 vaccine in healthy controls and people living with HIV (PLWH).<sup><xref rid="cit0037" ref-type="bibr">37</xref></sup> They found increased levels of <italic toggle="yes">Bifidobacterium</italic> pre-vaccination correlated with higher IgG titers, an association that held true in the PLWH cohort even in the context of HIV and antiretroviral therapy-related gut dysbiosis.<sup><xref rid="cit0044" ref-type="bibr">44&#8211;46</xref></sup></p><p>Following Ng <italic toggle="yes">et al</italic>.&#8217;s work, the same team conducted a subsequent analysis to investigate whether baseline microbiota could predict longer-term immunity, at six months post vaccination.<sup><xref rid="cit0035" ref-type="bibr">35</xref></sup> In the BNT162b2 group, high responders at six months showed a consistent abundance of <italic toggle="yes">B. adolescentis</italic> alongside <italic toggle="yes">B. bifidum</italic> and <italic toggle="yes">R. faecis</italic>. The Sinovac cohort showed a different pattern, with high responders characterized by increased <italic toggle="yes">Phocaeicola (Phocaeicola dorei)</italic>, and lower levels of <italic toggle="yes">Faecalibacterium prausnitzii</italic>. In contrast, <italic toggle="yes">F. prausnitzii</italic> was the most abundant species significantly associated with prolonged antibody half-life in BNT162b2 vaccinees.<sup><xref rid="cit0038" ref-type="bibr">38</xref></sup> These findings suggest that different vaccine types, with their distinct antigen presentations and adjuvant systems, may activate different immune pathways that are mediated by specific bacterial taxa. A secondary outcome measure in the Ng <italic toggle="yes">et al</italic>. study explored the correlation between microbiota and vaccination-related adverse effects, namely injection site pain, fatigue, fever, myalgia, drowsiness, headache and chills. Notably, two <italic toggle="yes">Megamonas</italic> species and <italic toggle="yes">Segatella copri</italic> correlated with reduced adverse effects following Sinovac and BNT162b2 vaccines.<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup> Interestingly, a separate cohort study of BNT162b2 vaccinees in Canada found higher levels of <italic toggle="yes">Prevotella</italic> pre-vaccination were associated with higher IgG levels.<sup><xref rid="cit0036" ref-type="bibr">36</xref></sup> In fact, the taxa found to be more abundant in high responders in the Canadian cohort differed significantly from those in Ng <italic toggle="yes">et al</italic>.&#8217;s Chinese cohort, including <italic toggle="yes">R. gnavus</italic>, which Ng <italic toggle="yes">et al</italic>. had found to be associated with lower antibody response in their 2022 study. Ng <italic toggle="yes">et al</italic>.&#8217;s follow up study identified <italic toggle="yes">Ruminococcus bicirculans</italic> as particularly abundant in BNT162b2&#160;high responders.<sup><xref rid="cit0039" ref-type="bibr">39</xref></sup> Han <italic toggle="yes">et al</italic>. found a different <italic toggle="yes">Ruminococcus species</italic> (<italic toggle="yes">R. toques</italic>) in higher abundance in high responders to the Sinovac vaccine, alongside <italic toggle="yes">Clostridium leptum and Lactobacillus&#8201;ruminis</italic>.<sup><xref rid="cit0030" ref-type="bibr">30</xref></sup> However, within this study, <italic toggle="yes">S. copri</italic> correlated with decreased IgG production.</p><p>An intriguing pattern emerges regarding the role of pro-inflammatory bacteria in vaccine immunogenicity. <italic toggle="yes">Bilophila</italic>, typically associated with IBD,<sup><xref rid="cit0047" ref-type="bibr">47</xref></sup> consistently correlated with enhanced antibody responses across multiple studies. In a UK study of 42 anti-TNF-treated patients with IBD receiving either BNT162b2 or ChAdOx1 vaccines, <italic toggle="yes">Bilophilia</italic> levels at baseline were correlated with final IgG titers.<sup><xref rid="cit0032" ref-type="bibr">32</xref></sup> A similar finding was reported in a US-based study, where elevated <italic toggle="yes">Bilophila (Desulfobacterota</italic>) levels in cohorts receiving BNT162b2 and Spikevax vaccines were correlated with higher IgG titers.<sup><xref rid="cit0034" ref-type="bibr">34</xref></sup> Collectively, these studies highlight that a microbiota with pro-inflammatory genera, such as <italic toggle="yes">Bilophila</italic>, may prime immune responses and enhance vaccine immunogenicity, particularly in populations with underlying inflammatory conditions. In contrast, <italic toggle="yes">S. copri</italic> displays a more complex immunological profile. Whilst implicated in numerous disease processes, including inflammatory bowel disease,<sup><xref rid="cit0048" ref-type="bibr">48</xref></sup> non-small cell lung cancer,<sup><xref rid="cit0049" ref-type="bibr">49</xref></sup> rheumatoid arthritis<sup><xref rid="cit0050" ref-type="bibr">50</xref></sup> and inflammation secondary to HIV,<sup><xref rid="cit0051" ref-type="bibr">51</xref></sup> in some Crohn&#8217;s disease pre-clinical models, <italic toggle="yes">S. copri</italic> was found to be less abundant than in healthy controls.<sup><xref rid="cit0052" ref-type="bibr">52</xref></sup> In colorectal cancer patients, significant depletion of <italic toggle="yes">S. copri</italic> was associated with an aberrant microbiota profile,<sup><xref rid="cit0053" ref-type="bibr">53</xref></sup> highlighting its potentially pleomorphic role in microbial-immune interplay. Indeed, in the context of vaccine response, <italic toggle="yes">S. copri</italic> was associated with reduced adverse effects but also correlated with lower antibody titers,<sup><xref rid="cit0030" ref-type="bibr">30</xref></sup> indicating a potential trade-off between vaccine tolerability and immunogenicity.</p><p>Whilst most studies have focused on the association between baseline microbiota and vaccine response, other studies have looked at changes in the microbiota following vaccination. There are different patterns seen in gut microbiota changes post vaccination. A study investigating the BBIBP-CorV vaccine found that gut microbiota diversity decreased in healthy adults post vaccination.<sup><xref rid="cit0031" ref-type="bibr">31</xref></sup> Similarly, Peng <italic toggle="yes">et al</italic>. found that in both BNT162b2 and Sinovac cohorts, participants had decreased abundances of Bacillota and Actinomycetota, and increased abundances of Bacteroidota and Pseudomonadota at 6 months. These results corresponded to a reduced Gram-positive to Gram-negative ratio of gut microbiota post-vaccination, which is a potential marker of an increased inflammatory gut status.<sup><xref rid="cit0054" ref-type="bibr">54</xref></sup></p><p>In summary, studies suggest that specific gut bacteria may influence immune response to COVID-19 vaccines. High responders to Sinovac and BNT162b2 vaccines often showed elevated levels of <italic toggle="yes">B. adolescentis</italic> and <italic toggle="yes">B. bifidum</italic> among other SCFA-producers whilst <italic toggle="yes">S. copri</italic> correlated with fewer side effects but also lower antibody levels. Pro-inflammatory bacteria, such as <italic toggle="yes">Bilophila</italic>, were associated with enhanced antibody responses, especially in inflammatory conditions.</p></sec><sec disp-level="2" id="s0002-s2003"><label>2.3.</label><title>Other parenteral vaccines</title><p>Whilst the majority of studies on the microbiota and response to parenteral vaccines have been conducted in the context of the COVID-19 pandemic, several studies have addressed other vaccines, namely the BCG, TT, Hep B, influenza, PCV13 and Infanrix Hexa vaccines. As highlighted in the COVID-19 vaccine studies, <italic toggle="yes">Bifidobacterium</italic> is emerging as a potential modulator of vaccine immunogenicity, as many studies have demonstrated a positive correlation between <italic toggle="yes">Bifidobacteria</italic> and enhanced antibody production.<sup><xref rid="cit0028" ref-type="bibr">28</xref>,<xref rid="cit0035" ref-type="bibr">35&#8211;37</xref></sup> Similarly, Huda <italic toggle="yes">et al</italic>. found the abundance of Actinomycetota, especially <italic toggle="yes">Bifidobacterium</italic>, was positively associated with BCG, TT and Hep B T cell responses.<sup><xref rid="cit0040" ref-type="bibr">40</xref></sup> A later study by the same group corroborated these findings, with increased levels of <italic toggle="yes">Bifidobacterium</italic> correlating with increased IgG and CD4<sup>+</sup> titers across the BCG, TT and Hep B vaccines, suggesting this bacterial genus may have a role in enhancing vaccine response across diverse antigens.<sup><xref rid="cit0041" ref-type="bibr">41</xref></sup> Conversely, Moroishi <italic toggle="yes">et al</italic>. showed that an abundance of <italic toggle="yes">Aeriscardovia aeriphila</italic> was associated with reduced TT-specific IgG antibodies.</p><p>Studies in animal models have established a link between the gut microbiota and antibody responses to the influenza vaccine,<sup><xref rid="cit0055" ref-type="bibr">55</xref></sup> which is now the subject of further investigation in humans. Hagan <italic toggle="yes">et al</italic>.&#8217;s seminal trial demonstrated the impact of antibiotics to modulate vaccine response by administering a five-day course of an oral broad-spectrum antibiotic regimen (neomycin, vancomycin, and metronidazole) to participants with no influenza exposure in the previous three years, before they received the influenza vaccine.<sup><xref rid="cit0056" ref-type="bibr">56</xref></sup> Their immune responses were compared to controls. The antibiotic intervention hindered the antibody production against the H1N1 A/California-specific virus. The antibiotics disrupted secondary bile acid production, particularly of lithocholic acid (LCA), thereby amplifying inflammatory signaling pathways (e.g., AP-1) and impairing antibody response. Similarly, in a COVID-19 vaccine study, the use of pre-immunization antibiotic treatment was associated with a significant 74% lower rate of seroconversion of neutralizing antibodies after one dose of the BNT162b2 vaccine.<sup><xref rid="cit0057" ref-type="bibr">57</xref></sup> These findings suggest that the immune-modulating properties of gut bacteria may not be universal, but rather context-dependent, influenced by factors such as vaccine type, microbial diversity and host health status.</p><p>A recent prospective study by Ryan <italic toggle="yes">et al.</italic>, following 191 infants from birth through 15&#8201;months, provided critical insights into the impact of antibiotic exposure timing on vaccine immunogenicity.<sup><xref rid="cit0043" ref-type="bibr">43</xref></sup> Specifically, reduced abundances of <italic toggle="yes">Bifidobacterium</italic> species (<italic toggle="yes">B. breve</italic>, <italic toggle="yes">B. pseudocatenulatum</italic> and <italic toggle="yes">B. bifidum</italic>) at six&#160;weeks strongly correlated with lower antibody responses against polysaccharide antigens in PCV13 and Infanrix Hexa vaccine antigens at seven months. Functional analyses further confirmed impaired opsonophagocytic activity against PCV13 serotype PPS6B. Notably, these effects were specific to neonatal antibiotic exposure; intrapartum antibiotics did not significantly impact microbiota or vaccine responses. Ryan <italic toggle="yes">et al</italic>.&#8217;s findings extend prior observations made by Hagan <italic toggle="yes">et al</italic>., by explicitly linking antibiotic-induced microbiota disruptions to impaired vaccine responses and further highlighting the importance of the timing of microbiota disruption in determining subsequent vaccine efficacy. This study provides compelling new evidence that early-life reductions in <italic toggle="yes">Bifidobacterium</italic> significantly impact vaccine immunogenicity, reinforcing the central role of <italic toggle="yes">Bifidobacterium</italic> as a largely consistent predictor of enhanced vaccine response across various vaccines and age groups.</p><sec disp-level="3" id="s0002-s2003-s3001"><label>2.3.1</label><title>Factors affecting vaccine efficacy</title><p>As this review collates a diverse group of human studies, it is essential to acknowledge the intrinsic and extrinsic factors, such as geographical differences, that can modulate human gut microbiota composition. A study by Subramanian <italic toggle="yes">et al</italic>. from 2014 showed that malnourished Bangladeshi children had immature microbiota, predominantly consisting of <italic toggle="yes">Streptococcaceae</italic>, <italic toggle="yes">Fusobacteriaceae</italic> and <italic toggle="yes">Enterobacteriaceae</italic>, whilst having reduced levels of <italic toggle="yes">Lactobacillus</italic> and <italic toggle="yes">Bifidobacterium</italic> compared to healthy age-matched children.<sup><xref rid="cit0058" ref-type="bibr">58</xref></sup> The composition of the gut microbiota is highly variable between individuals, with notable distinctions between Westernized and non-Westernized populations. In rural African populations, the gut microbiota has higher concentrations of <italic toggle="yes">Prevotella</italic>, <italic toggle="yes">Treponema</italic>, and <italic toggle="yes">Clostridia</italic>, which is likely due to the individuals&#8217; high fiber and plant-based diets, whilst European populations tend to have higher levels of <italic toggle="yes">Bacteroidota</italic> and lower overall microbiota diversity.<sup><xref rid="cit0059" ref-type="bibr">59</xref></sup> Rothschild <italic toggle="yes">et al</italic>. found in 2018 that lifestyle and geography alone accounted for microbiota variation more than host genetics in more than 1000 individuals.<sup><xref rid="cit0060" ref-type="bibr">60</xref></sup> Among our studies, Asian populations consistently exhibit beneficial associations between <italic toggle="yes">B. adolescentis</italic> and enhanced vaccine immunogenicity across multiple vaccine platforms,<sup><xref rid="cit0028" ref-type="bibr">28</xref>,<xref rid="cit0035" ref-type="bibr">35</xref>,<xref rid="cit0041" ref-type="bibr">41</xref></sup> while Western populations show more heterogeneous <italic toggle="yes">Bifidobacterium</italic> relationships.<sup><xref rid="cit0036" ref-type="bibr">36</xref>,<xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0043" ref-type="bibr">43</xref></sup> Notably, certain taxa exhibit population-specific directional effects: <italic toggle="yes">F. prausnitzii</italic> is associated with enhanced responses in Swedish and South Korean cohorts<sup><xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0038" ref-type="bibr">38</xref></sup> but reduced response in the Hong Kong population.<sup><xref rid="cit0035" ref-type="bibr">35</xref></sup> Population-level differences in microbiota are likely to impact immune system maturation and mucosal tolerance, which partially influence the host&#8217;s ability to mount robust vaccine responses.</p><p>Age is a key determinant of vaccine response, and the gut microbiota evolves dramatically across the lifespan: early life is characterized by instability and low diversity with a small number of dominant bacterial families, transitioning to adult-like composition by ages two to three.<sup><xref rid="cit0061" ref-type="bibr">61</xref></sup> Adult microbiota exhibits high diversity and inter-individual heterogeneity with increased stability, while aging brings progressive decline in both diversity and stability.<sup><xref rid="cit0062" ref-type="bibr">62</xref></sup> Among human studies, infant populations universally demonstrate positive <italic toggle="yes">Bifidobacterium</italic>-vaccine associations across geographic locations, while adult populations exhibit more variable and contradictory patterns. This disparity may suggest that the early-life microbiota&#8217;s instability and limited diversity align with vaccine efficacy through more predictable immune modulation, whereas the increased complexity of adult microbiomes manifests with more variable vaccine responses. Importantly, existing COVID-19 vaccine studies have focused exclusively on adults while other parenteral vaccine trials (BCG, TT, HBV, OPV, PCV13 and Infanrix Hexa) were conducted in infants, highlighting a fundamental limitation in extrapolating findings across life stages given that infant gut microbiota undergoes significant compositional and diversity changes during early development that may not translate to established adult microbiomes.<sup><xref rid="cit0061" ref-type="bibr">61</xref></sup></p><p>Nonetheless, collectively, human studies highlight that <italic toggle="yes">Bifidobacterium</italic> demonstrates remarkable consistency as being positively associated with immune responses to vaccination across diverse vaccine platforms. High <italic toggle="yes">Bifidobacterium</italic> abundance (particularly <italic toggle="yes">B. adolescentis</italic>), presence of butyrate-producing taxa (<italic toggle="yes">Faecalibacterium</italic>, <italic toggle="yes">Roseburia</italic>), and context-dependent enrichment of pro-inflammatory genera (<italic toggle="yes">Bilophila</italic>) all show promise as modulators of vaccine-responsiveness. These exciting discoveries do not yet amount to a core microbiota signature of vaccine responsiveness, and further studies are needed accounting for geographical, age and disease-specific variation before such findings can be translated into clinical practice.</p></sec></sec><sec disp-level="2" id="s0002-s2004"><label>2.4.</label><title>Microbiota-derived metabolites and metabolic pathways</title><p>In addition to evaluating microbiota composition, some studies have also explored the metabolites and metabolic pathways that may influence immune responses to vaccines.</p><p>Bacteria such as <italic toggle="yes">E. rectale</italic> and <italic toggle="yes">R. faecis</italic> are both SCFA producers and have been linked to an increased antibody response in BNT162b2 vaccinees,<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup> suggesting certain microbiota-derived metabolites may act as adjuvants to vaccines. Indeed, in the BBIBP-CorV cohort study, Tang <italic toggle="yes">et al</italic>. found that serum levels of SCFAs, namely acetic acid, butyric acid and isovaleric acid, correlated with increased antibody response at day 42 post vaccination.<sup><xref rid="cit0031" ref-type="bibr">31</xref></sup> Notably, they found fecal and serum levels of SCFAs were higher in high responders compared to low responders, indicating they may have a role in improving antibody response post BBIBP-CorV vaccination.</p><p>In a BNT162b2 study, the group with a longer antibody half-life showed significant enrichment of <italic toggle="yes">F. prausnitzii</italic>, which is a key butyrate-producing bacterium.<sup><xref rid="cit0038" ref-type="bibr">38</xref></sup> Other SCFA-producing bacteria, including <italic toggle="yes">Prevotella</italic> and <italic toggle="yes">Bacteroides, Ruminococcaceae</italic> and <italic toggle="yes">Lachnospiraceae</italic> were also notably abundant in this group. Similarly, Alexander <italic toggle="yes">et al</italic>. found that butyrate-producing bacteria (e.g., <italic toggle="yes">Butyricicoccus</italic>) and the BCFA, isobutyrate, were enriched in high responders.<sup><xref rid="cit0032" ref-type="bibr">32</xref></sup>
<italic toggle="yes">Ruminococcaceae</italic> emerges as a key player in vaccine response based on Ng et al.&#8216;s recent findings of abundant <italic toggle="yes">R. bicirculans</italic> in BNT162b2&#160;high responders.<sup><xref rid="cit0039" ref-type="bibr">39</xref></sup> This genus synthesizes SCFAs including butyrate, propionate and acetate, with butyrate playing a specific role in boosting antibody production by upregulating follicular helper T cells necessary for plasma cell activation and differentiation.<sup><xref rid="cit0063" ref-type="bibr">63</xref>,<xref rid="cit0064" ref-type="bibr">64</xref></sup> However, some bacteria with SCFA-producing potential were also abundant in low responders. Peng <italic toggle="yes">et al</italic>. found that butyrate, isobutyrate, isovalerate, and benzenebutanoic acid were elevated in low responders to the BNT162b2 vaccine.<sup><xref rid="cit0035" ref-type="bibr">35</xref></sup> Moreover, high responders showed a different pattern of enriched metabolites, including nicotinic acid, &#947;-aminobutyric acid, fumaric acid, 2-aminoisobutyric acid, m-coumaric acid and threonic acid. In a subsequent BNT162b2 study, bacteria like <italic toggle="yes">Megasphaera</italic> spp., which are also prominent isovaleric and isobutyric acid producers, were associated with a poorer vaccine response.<sup><xref rid="cit0036" ref-type="bibr">36</xref></sup> These seemingly contradictory findings may be explained by several factors: measurement timing, local versus systemic concentrations of metabolites, the specific bacterial species producing them, and overall microbiota composition context. The differential metabolite profiles between high and low responders suggest that immunomodulatory effects may depend on the broader metabolic milieu rather than individual SCFA concentrations alone. Supporting this notion, Lunken <italic toggle="yes">et al</italic>. found that high dietary fiber intake enhanced IgG binding strength maturation between BNT162b2 doses while reducing total BCFAs post-vaccination, suggesting dietary modulation of the microbiome influences vaccine response.<sup><xref rid="cit0036" ref-type="bibr">36</xref></sup> These findings indicate that SCFA effects on COVID-19 vaccine immunogenicity are context-dependent, with no clear consensus on which specific fatty acids are consistently associated with antibody response.</p><p>When broad-spectrum antibiotic therapy was given to influenza vaccine recipients, changes in metabolic responses were observed, notably elevation of primary bile acids and a significant reduction in bacterially produced secondary bile acids, such as LCA, in comparison to non-antibiotic-treated controls.<sup><xref rid="cit0056" ref-type="bibr">56</xref></sup> The authors postulate that this reduction in secondary bile acids promotes a pro-inflammatory response, akin to that seen in elderly adults receiving influenza vaccination, which is detrimental to vaccine immunogenicity. Recent research by Ryan <italic toggle="yes">et al</italic>. has further detailed inflammatory consequences following neonatal antibiotic exposure, and their potential link to reduced antibody response.<sup><xref rid="cit0043" ref-type="bibr">43</xref></sup> Neonatal antibiotic exposure was associated with elevated baseline activity of inflammation-related blood transcriptional modules (BTMs). These BTMs, particularly monocyte-related, showed a negative correlation with several vaccine antibody responses measured at seven&#8201;months post-vaccination. Furthermore, causal mediation analyses revealed that increased abundance of beneficial bacteria such as <italic toggle="yes">B. breve</italic> and <italic toggle="yes">B. bifidum</italic> positively influenced PCV13 antibody (PPS6B IgG) titers by mediating inflammation-related BTM activity. Collectively, these findings support the idea that early-life antibiotic exposure may induce a pro-inflammatory state, which hinders the colonization of beneficial microbiota like <italic toggle="yes">Bifidobacterium</italic>, and compromises optimal vaccine immunogenicity.</p><p>Ng <italic toggle="yes">at al</italic>. found a higher abundance of <italic toggle="yes">B. adolescentis</italic> in high responders.<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup> This bifidobacterial enrichment was linked to an increase in the pathways involved in carbohydrate metabolism. Similarly, Moroishi <italic toggle="yes">et al</italic>. reported an association between TT vaccine response and the CDP-diacylglycerol biosynthesis I and II pathways, with CDP-diacylglycerol being a key component of lipid metabolism.<sup><xref rid="cit0042" ref-type="bibr">42</xref></sup> Ng <italic toggle="yes">et al</italic>. also observed a positive correlation between the enrichment genes involved in flagellin and pili production, and IgG levels post BNT162b2 and Sinovac vaccination. This relationship between cell motility genes and antibody response was corroborated by Daddi <italic toggle="yes">et al.</italic>, who found gene markers for flagellin, pili and capsular polysaccharides were positively correlated with final levels of IgG post BNT162b2 and Spikevax vaccination.<sup><xref rid="cit0034" ref-type="bibr">34</xref></sup> These findings collectively highlight the potential role of carbohydrate and lipid metabolism, as well as cell motility and polysaccharide biosynthesis, in modulating immune responses to vaccines.</p></sec><sec disp-level="2" id="s0002-s2005"><label>2.5.</label><title>Limitations</title><p>The majority of human studies thus far have been observational, which precludes establishing causality between microbiota, metabolomic changes and vaccine immune responses. Moreover, some studies had small sample sizes, and the ethnic and geographic disposition of participants may have limited their ability to identify generalizable correlates of adaptive immune responses. In many studies, microbiota analysis was conducted via 16S rRNA gene amplicon sequencing rather than by shotgun metagenomics, allowing for examination of taxonomic profile differences in the gut microbiota between high and low antibody responders at the genus level, but not at the species or strain level. Similarly, the distinction between IgG antibody titers and neutralizing antibody assays reflects different aspects of the immune response. IgG levels indicate exposure and general antibody production, whereas neutralizing antibodies specifically measure functional immunity against viral infections. These methodological differences limit cross-study comparability and may explain inconsistencies in reported microbiota-immune associations. Moreover, most analyses of bacterial taxa rely on relative abundances, which are influenced by the abundance of other taxa and the further reliance on 16S rRNA amplicon sequencing to measure taxonomic abundance, with limited integration of functional data such as metagenomics, metabolomics or transcriptomics, which remains a key limitation. Due to the high degree of functional redundancy within the gut microbiota, changes in taxa do not necessarily demonstrate how immune responses to vaccinations will be impacted. Similarly, without measuring fecal SCFA levels, immune modulatory effects cannot be reliably inferred from taxonomic relative abundances alone, given SCFA production capacity varies significantly even among closely related bacterial species. Future studies using absolute quantification are needed and functional profiling will likely provide further mechanistic insight into the influence of the gut microbiota on vaccine immunogenicity. Function-focused approaches should be prioritized to better understand biological mechanisms and identify microbial targets for novel therapeutics. Additionally, diet plays a key role in influencing both microbiota composition and metabolite production. While most studies have not adjusted for dietary habits, recent papers by Lunken <italic toggle="yes">et al</italic>. and Ng <italic toggle="yes">et al</italic>. have begun exploring and accounting for diet<sup><xref rid="cit0036" ref-type="bibr">36</xref>,<xref rid="cit0039" ref-type="bibr">39</xref></sup> - an important consideration for future work given the central role of diet in modulating microbiota composition and function, as well as direct dietary effects on immune responses.</p></sec></sec><sec disp-level="1" id="s0003"><label>3.</label><title>Experimental model data (in vitro/animal studies)</title><sec disp-level="2" id="s0003-s2001"><label>3.1.</label><title>Overview</title><p>A growing body of research is being conducted on the relationship between gut microbiota and its effects on both the adaptive and innate immune systems in the context of vaccination. Most studies focus on antibiotic-induced changes in the gut microbiota composition using murine models. Other research has explored the effects of dietary modifications, microbiota-derived metabolites, and germ-free (GF) conditions on immune cell composition and function. The findings from these studies shed light on how gut microbiota influences T and B cell responses, which are essential for vaccine-induced immunity (<xref rid="f0002" ref-type="fig">Figure 2</xref>). Understanding the relationship between gut microbiota composition and the immune system at cellular and molecular levels provides foundational knowledge for optimizing vaccine efficacy.<fig position="float" id="f0002" fig-type="figure" orientation="portrait"><label>Figure 2.</label><caption><p>Microbiota mediated factors influencing vaccine efficacy. The diagram highlights how the healthy microbiome, its metabolites, dietary changes and antibiotic-induced dysbiosis can modulate the immune cell composition and therefore impact vaccine efficacy. Green arrows represent a positive impact (i.e. an increase); red arrows represent a negative impact (i.e. a decrease). Created in BioRender. Roberts, L. (2025) <ext-link xlink:href="https://BioRender.com/rs9azln" ext-link-type="uri">https://BioRender.com/rs9azln</ext-link></p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KGMI_A_2549585_F0002_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KGMI_A_2549585_F0002_PB.jpg"/></alternatives></fig></p></sec><sec disp-level="2" id="s0003-s2002"><label>3.2.</label><title>Germ-free models &#8211; microbiota-free animals</title><p>Germ-free (GF) mice have lower numbers of CD4<sup>+</sup> cells and defective mesenteric lymph nodes and spleens.<sup><xref rid="cit0065" ref-type="bibr">65</xref></sup> They have a reduced Th1 immune response with a clear bias toward Th2 responses. Their spleens are smaller and have fewer germinal centers, which are common sites for B-cell maturation, resulting in severely reduced natural IgG serum levels. The impact of the low natural antibody levels was seen when GF mice were injected with the PCV13 vaccine, which resulted in significantly lower PCV13-specific IgG and IgM responses.<sup><xref rid="cit0043" ref-type="bibr">43</xref></sup> GF mice are also lacking in intestinal Th17 response,<sup><xref rid="cit0066" ref-type="bibr">66</xref></sup> and such mice colonized with intestinal bacteria display increased Th17 cell numbers.</p></sec><sec disp-level="2" id="s0003-s2003"><label>3.3.</label><title>Microbiota-derived metabolites and products</title><p>The bacteria that make up the gut microbiota produce various metabolites with immunomodulatory properties. The changes in the immune cell composition can then impact the body&#8217;s response to the vaccines, as discussed above. For example, some bile acid secondary metabolites, such as 3-oxolithocholic acid, have been found to bind to ROR&#947;t, the key transcription factor of Th17 cells, inhibiting their differentiation,<sup><xref rid="cit0066" ref-type="bibr">66</xref></sup> whilst SCFAs promote na&#239;ve T-cell differentiation to Th1 and Th17 cells and increase IL-10 expression.<sup><xref rid="cit0067" ref-type="bibr">67</xref></sup> IL-10 promotes Treg formation and forms a negative feedback mechanism for SCFA-promoted T-cell generation and differentiation.<sup><xref rid="cit0068" ref-type="bibr">68</xref></sup> Hence, SCFAs produced by the gut microbiota promote effector and Treg cell differentiation, thus having the potential to both stimulate and regulate the immune response to vaccinations.</p><p>However, a paper from 2021 reported some contradictory data comparing metabolite effects on innate and adaptive immune functions.<sup><xref rid="cit0069" ref-type="bibr">69</xref></sup> Increased SCFA levels, such as butyrate, were associated with decreased intestinal innate lymphoid cell (ILC) proliferation and migration to the lung in influenza A infection.<sup><xref rid="cit0070" ref-type="bibr">70</xref></sup> ILC2 cells play a role in modulating respiratory viral infection by differentiating into ILC1 cells, which subsequently enhance antiviral responses and have been shown to improve response to influenza vaccines.<sup><xref rid="cit0071" ref-type="bibr">71</xref>,<xref rid="cit0072" ref-type="bibr">72</xref></sup> Mice with reduced ILC2 function and defective migration of dendritic cells to the lungs due to antibiotic-driven dysbiosis were injected with lipopolysaccharides (LPS), produced and found in Gram-negative bacteria, which corrected the immune function in influenza A infection and may also improve response to vaccination.<sup><xref rid="cit0073" ref-type="bibr">73</xref></sup> The gut microbiota metabolites, such as SCFA, can have both pro-inflammatory and anti-inflammatory effects during acute infection and alter immune cell composition, impacting response to vaccinations. The ILCs have SCFA receptors at different concentrations depending on their origin, hence it is challenging to determine the overall impact SCFA has on the immune cell composition and on vaccine response.<sup><xref rid="cit0069" ref-type="bibr">69</xref></sup> The reduction of ILC proliferation and migration due to increased SCFA levels was also mainly observed in patients with COPD, having a beneficial effect on their disease activity.<sup><xref rid="cit0070" ref-type="bibr">70</xref></sup> It is therefore also crucial to investigate if this effect is seen in healthy individuals across various age groups. Although animal models show promising results in improving immune function with certain bacterial products or metabolite supplementation, further research is warranted to investigate the ideal concentrations for therapeutic effects, such as optimum vaccine efficacy.</p></sec><sec disp-level="2" id="s0003-s2004"><label>3.4.</label><title>Dietary changes</title><p>Gut microbiota composition is closely linked to dietary intake, with bacterial taxa and their metabolite concentrations heavily influenced by interventional diets, such as high fiber, high protein or high fat.<sup><xref rid="cit0074" ref-type="bibr">74</xref></sup> Hence, dietary changes and their effects on vaccine efficacy have been investigated using murine models. In one study, mice on a gluten-free diet received the TT vaccine, and their IgG titers and immune cell levels were investigated.<sup><xref rid="cit0075" ref-type="bibr">75</xref></sup> These mice had significantly lower antibody levels than the control group. They also had reduced levels of T-cells, specifically CD8<sup>+</sup>, in their mesenteric lymph nodes and reduced numbers of activated CD4<sup>+</sup> cells. However, in their spleen, both CD4<sup>+</sup> and CD8<sup>+</sup> cells were more abundant.</p><p>Another study found that high-fiber diets were associated with higher levels of Treg cells, whilst high-fat diets were associated with low-grade inflammation and increased numbers of intraepithelial lymphocytes.<sup><xref rid="cit0076" ref-type="bibr">76</xref></sup> Mice with diet-induced obesity were vaccinated against influenza and injected with the H1N1 virus, which showed different immune responses to their control group.<sup><xref rid="cit0077" ref-type="bibr">77</xref></sup> The number of B cells produced was similar. However, the obese mice had more severe systemic inflammation, as T-cell maturation to memory cells was limited. The prolonged maturation of T-cells into memory cells caused prolonged activation of the T-cells and, hence, an extended inflammatory state in the mouse. The metabolic dysfunction of the T-cells was reversible if mice switched their diet back to the control diet prior to vaccination, leading to a 100% survival rate compared to 0% in continuously obese mice. Similarly, mice with diet-induced obesity and diabetes mellitus vaccinated against COVID-19 were found to have increased neutrophil levels in the lungs post-infection.<sup><xref rid="cit0078" ref-type="bibr">78</xref></sup> Although antibody titers to the vaccine were similar to the control group, these mice had reduced viral clearance and higher mortality rates, suggesting decreased vaccine efficacy. These studies demonstrate that dietary alterations may impact the gut microbiota significantly to cause variations in the immune response and hence impact vaccine-induced immunity.</p></sec><sec disp-level="2" id="s0003-s2005"><label>3.5.</label><title>Antibiotic-induced microbiota perturbation</title><p>Various studies investigated how antibiotic-induced perturbations of the gut microbiota affect parenteral vaccine efficacy. It should be noted that broad-spectrum antibiotics may directly impact immune cell function, including that of lymphocytes and macrophages, independent of microbiota changes,<sup><xref rid="cit0079" ref-type="bibr">79</xref>,<xref rid="cit0080" ref-type="bibr">80</xref></sup> but here we will focus on research linking antibiotic-driven microbiota perturbation to impaired immune response to vaccination. Kihl <italic toggle="yes">et al</italic>. investigated IgG titers and immune cell levels in murine models that were fed ampicillin and received the TT vaccine and booster.<sup><xref rid="cit0075" ref-type="bibr">75</xref></sup> The antibiotic-treated mice had lower numbers of Bacteroidota and significantly lower antibody levels than untreated mice. They also had impaired peripheral immunity, demonstrated by their reduced fractions of CD3<sup>+</sup> and CD4<sup>+</sup> cells in the mesenteric lymph nodes and lower numbers of activated T-cells in the spleen. The results indicate that antibiotic-induced perturbation of the gut microbiota can lead to lower antibody levels and reduced overall efficacy of the TT vaccine.</p><p>Similarly, a study by Oh <italic toggle="yes">et al</italic>. from 2014 showed that mice treated with antibiotics or raised germ-free had significantly reduced IgG responses to the inactivated influenza vaccine.<sup><xref rid="cit0081" ref-type="bibr">81</xref></sup> This was due to low levels of Toll-like receptor five (TLR5). When the researchers restored microbiota using flagellated commensals or directly administered purified flagellin, vaccine responses improved. This finding demonstrates that microbiota-derived flagellin signals via TLR5 are essential for effective humoral immunity.</p><p>Interestingly, another study investigating vaccine efficacy in mice showed that both antibiotic-treated and GF mice did not significantly decrease their IgG responses to the BNT162b2 vaccination.<sup><xref rid="cit0082" ref-type="bibr">82</xref></sup> The difference in T-cell response was also not significant, and neither was the number of B-cells or Th-cells in the vaccine-draining iliac lymph nodes.</p><p>In a study where young mice received the BCG vaccine, their IgG1, IgG2c and IgM antibody levels were lower if they had been exposed to ampicillin and neomycin during gestation.<sup><xref rid="cit0083" ref-type="bibr">83</xref></sup> When giving a booster dose, the antibody levels did not improve. Their antibody levels were also reduced to other vaccinations commonly given to infants during their routine vaccination schedule, such as Meningitis B and C, PCV13 and the Hexavalent combination vaccine. The mice had increased levels of <italic toggle="yes">Enterobacter</italic>, which can be a common microbiota change following antibiotic exposure.<sup><xref rid="cit0084" ref-type="bibr">84</xref></sup> An overgrowth of <italic toggle="yes">Enterobacter</italic> bacteria has been associated with the suppression of SCFAs and an increase in LPS production.<sup><xref rid="cit0085" ref-type="bibr">85</xref></sup> Interestingly, adult mice who received the same antibiotic dosages as the mothers during pregnancy had a normal immune response to the PCV13 vaccine, even though the antibiotic-driven microbiota perturbation was similar. There were also no changes in the IgG levels of adult mice continuously exposed to antibiotics compared to the control group. Young antibiotic-treated mice that received FMT from the control group did not have impaired IgG responses to the PCV13 vaccination. These results show the vulnerability of the gut microbiota at early stages of life, especially during gestation. It also provides further insight into the possibility of microbially targeted therapeutics as management for antibiotic-induced microbiota perturbation and improvement in vaccine responses.</p><p>In addition to altering metabolite concentrations, an overgrowth of <italic toggle="yes">Enterobacter</italic> leads to an imbalance of the T-cell population, specifically Th1, Th2, Th17 and Treg cells.<sup><xref rid="cit0086" ref-type="bibr">86</xref></sup> Treg cells develop in recipients of vaccinations to regulate the immune response when they get infected, commonly seen in vaccinated COVID-19 patients.<sup><xref rid="cit0087" ref-type="bibr">87</xref></sup> This imbalance in T-cells may lead to the development of autoimmune and inflammatory diseases, as well as reduce vaccine-induced immunity and therefore lead to higher infection rates and more severe infections.</p><p>A recent study by Feng <italic toggle="yes">et al</italic>. demonstrated that both antibiotic-treated and germ-free mice receiving the rabies vaccine had reduced antibody production and T-helper cell populations in draining lymph nodes.<sup><xref rid="cit0088" ref-type="bibr">88</xref></sup> The mice also showed a Th1-biased immune response, disrupting the balance that is required for optimal germinal center and memory B cell formation. Additionally, antibiotic-induced perturbations of the microbiota resulted in lower concentrations of secondary bile acids, like deoxycholic acid. However, supplementing these metabolites restored vaccine immunogenicity. The study also showed that broad-spectrum antibiotic use in humans significantly impairs both primary and memory immune responses to the rabies vaccine in healthy adults. The participants had impaired B-cell activation and reduced antibody titers, which lasted up to 180&#8201;days post vaccination. These findings provide mechanistic evidence that bile acid signaling may be a key link between vaccine immunogenicity and the gut microbiome.</p><p>Lastly, a study investigated the impacts that perturbation of the microbiota had on lung immune cell infiltration. Mice were vaccinated with the BCG or L91 tuberculosis vaccine and given a booster after 15&#8201;days.<sup><xref rid="cit0089" ref-type="bibr">89</xref></sup> Sixty days after inoculation, one group of mice received an antibiotic cocktail orally consisting of amphotericin B, trimethoprim, polymyxin, vancomycin and carbenicillin, followed by exposure to <italic toggle="yes">Mycobacterium tuberculosis</italic> via the air 21&#8201;days later. The antibiotics were continued to maintain microbiome dysbiosis. The antibiotics-treated mice had a significantly reduced number of taxa, showing a reduction in microbiota diversity. There was a decrease in the number of <italic toggle="yes">Bifidobacterium</italic> and <italic toggle="yes">Lactobacillus</italic> families, but an increase in <italic toggle="yes">Bacteroides</italic>. Both CD4<sup>+</sup> and CD8<sup>+</sup> cells were less proliferated in the antibiotic-treated mice. The intervention group had lung-specific immune differences compared to the control group. They had a significantly higher disease burden in their lungs. There was a lower activation of T-cells in the lung with reduced expression of the CD44 and CD127 activation markers and reduced effector CD4<sup>+</sup> and CD8<sup>+</sup> memory T-cell populations. There was also a significant reduction in resident memory T-cells, which play an important role in the protection from respiratory pathogens such as tuberculosis or respiratory syncytial virus.<sup><xref rid="cit0090" ref-type="bibr">90</xref></sup> The antibiotic-treated mice had drastically reduced central T-memory cells in the spleen and lymph nodes, which are the homing sites. This work demonstrates that antibiotic-induced dysbiosis delays vaccine-induced immune response and impacts the immune function at the primary site of infection and secondary lymphoid organs by impairing systemic T-cell function.<sup><xref rid="cit0079" ref-type="bibr">79</xref>,<xref rid="cit0080" ref-type="bibr">80</xref></sup></p></sec></sec><sec disp-level="1" id="s0004"><label>4.</label><title>Future directions</title><p>In this review, we have discussed evidence linking the composition and function of the gut microbiota to immune responses to vaccination, raising the question whether modulating the microbiota (or its products) might be a means to improve vaccine efficacy. A number of experimental approaches have been assessed, including dietary modification, co-stimulation with pro-inflammatory LPS and even FMT.<sup><xref rid="cit0083" ref-type="bibr">83</xref>,<xref rid="cit0086" ref-type="bibr">86</xref>,<xref rid="cit0091" ref-type="bibr">91</xref></sup> A recent study showed promising results in GF mice, where <italic toggle="yes">B. bifidum</italic> and <italic toggle="yes">Lactobacillus acidophilus</italic> were administered a week before PCV13 vaccination and resulted in significantly increased vaccine-specific antibody levels.<sup><xref rid="cit0043" ref-type="bibr">43</xref></sup> In human studies, both probiotics (cocktails of bacteria with supposedly beneficial properties) and prebiotics (non-digestible products that promote probiotic microbiota growth) have been investigated for their potential to improve vaccine response.<sup><xref rid="cit0092" ref-type="bibr">92</xref></sup> Clinically, commonly used probiotics include <italic toggle="yes">Bifidobacterium</italic>, <italic toggle="yes">Lactobacillus</italic>, non-lactic acid bacteria and yeasts.<sup><xref rid="cit0091" ref-type="bibr">91</xref></sup> Common prebiotics, including inulin, fructo-oligosaccharides (FOS), and galacto-oligosaccharides (GOS), have been linked to increasing <italic toggle="yes">Bifidobacterium and Lactobacillus</italic> numbers and gut IgA titers in animal models.<sup><xref rid="cit0093" ref-type="bibr">93&#8211;95</xref></sup>
<italic toggle="yes">Bifidobacterium infantis</italic> and <italic toggle="yes">Lactobacillus</italic> show evidence of moderating immune function and reducing secondary infection in COVID-19.<sup><xref rid="cit0031" ref-type="bibr">31</xref>,<xref rid="cit0096" ref-type="bibr">96</xref></sup></p><p>Similarly, a six week course of <italic toggle="yes">Bifidobacterium lactis</italic> and <italic toggle="yes">Lactobacillus paracasei</italic> following the influenza vaccine resulted in higher IgG and IgA titers and seroconversion rates.<sup><xref rid="cit0097" ref-type="bibr">97</xref></sup> Another study found the use of <italic toggle="yes">L. paracasei, Lactobacillus bulgaricus</italic>, and <italic toggle="yes">Streptococcus thermophilus</italic> over 13&#8201;weeks also led to higher IgG levels and seroconversion rates several weeks post influenza vaccination.<sup><xref rid="cit0098" ref-type="bibr">98</xref></sup> Indeed, meta-analysis indicates that probiotics may have a role in boosting responses in vulnerable older people, but larger, high-quality trials are needed.<sup><xref rid="cit0099" ref-type="bibr">99</xref></sup> Evidence suggests the use of concomitant pre- and probiotics can enhance hemagglutination inhibition antibody titers post influenza vaccination.<sup><xref rid="cit0100" ref-type="bibr">100</xref></sup> There are rare cases of bacteremia when using probiotics in immunocompromised individuals, but as Yeh <italic toggle="yes">et al.&#8217;s</italic> subgroup analyses showed similar effects between prebiotic and probiotic supplementation, prebiotics could be considered an alternative.<sup><xref rid="cit0101" ref-type="bibr">101</xref></sup></p><p>Other probiotic preparations including <italic toggle="yes">Lacticaseibacillus rhamnosus GG (LGG)</italic>, <italic toggle="yes">Lactiplantibacillus plantarum</italic> and <italic toggle="yes">Pediococcus acidilactici KABP021</italic> have shown promise in reducing the severity of active COVID-19 infection. Participants in multiple placebo-controlled trials experienced delayed onset of COVID-19 and fewer symptoms, including post-COVID syndrome.<sup><xref rid="cit0102" ref-type="bibr">102&#8211;104</xref></sup> However, Jesperson <italic toggle="yes">et al</italic>. found <italic toggle="yes">L. paracasei</italic> only had positive symptomatic effects.<sup><xref rid="cit0105" ref-type="bibr">105</xref></sup> LGG has also had positive results in influenza vaccinees, with increased IgA and IgG titers following the use of <italic toggle="yes">LGG, L. plantarum and Lactobacillus fermentum</italic>.<sup><xref rid="cit0106" ref-type="bibr">106</xref>,<xref rid="cit0107" ref-type="bibr">107</xref></sup> Moreover, maternal <italic toggle="yes">LGG</italic> supplementation showed a decrease in specific antibody responses in TT, <italic toggle="yes">Haemophilus influenzae</italic> type b (Hib), and PCV vaccines in infants, showing there is a scope for modulation, but it was not beneficial in improving vaccine-specific immunity.<sup><xref rid="cit0108" ref-type="bibr">108</xref></sup> Collectively, probiotics demonstrate significant potential in regulating gut microbiota and thereby enhancing immune function post vaccination, although a full exploration of this potential is beyond the scope of this review.</p><p>In addition to probiotics, synbiotics, which combine probiotics with prebiotics to allow optimal growth of beneficial microbial cultures, have been investigated for modulating the gut microbiota and thus enhancing vaccine immunogenicity. A double-blinded, human randomized controlled trial found that supplementation of <italic toggle="yes">Bifidobacterium longum</italic> with gluco-oligosaccharide had no significant effect on B-cell or T-cell responses to seasonal influenza vaccinations.<sup><xref rid="cit0109" ref-type="bibr">109</xref></sup> To date, only a limited number of human trials have evaluated synbiotics in this context, with no evidence of a significant benefit of synbiotic supplementation on vaccine response. Further research is required to better understand the mechanisms by which synbiotics may influence vaccine immunogenicity and to identify optimal strain concentrations. Similarly, although animal models have shown promising results in using FMT trials to improve vaccine immunogenicity,<sup><xref rid="cit0024" ref-type="bibr">24</xref>,<xref rid="cit0110" ref-type="bibr">110</xref></sup> these findings have yet to be validated in humans. Additionally, microbiota-based interventions remain unexplored across certain vaccine types, including the mRNA vaccine platforms, which have unique mechanisms of action and therefore may require tailored strategies.</p><p>Finally, despite growing interest in these approaches, the implementation of microbiota screening or manipulation into routine vaccine programs presents logistical and ethical challenges. Implementing large-scale microbiota screening would require a significant investment in infrastructure and bioinformatics capacity. Microbiota modulation methods for example, with FMT, are currently costly and not routinely available outside of specialist centers, making them inaccessible in the context of population-wide vaccination programs administered via primary care.<sup><xref rid="cit0111" ref-type="bibr">111</xref></sup> Moreover, with vaccine hesitancy and non-uptake being the key barriers to effective herd immunity against common pathogens, the introduction of additional hurdles aimed at improving vaccine efficacy might actually result in poorer levels of immunity overall.<sup><xref rid="cit0112" ref-type="bibr">112</xref></sup></p></sec><sec disp-level="1" id="s0005"><label>5.</label><title>Conclusion</title><p>In this review, we have examined the evidence linking the gut microbiome to immune responses to parenterally delivered vaccines. We have explored research in pre-clinical models, which indicates that dysbiosis of the gut microbiota can negatively impact such responses. These show the gut microbiota playing a role in modulating T-cell subsets, antibody production, and immune regulation. Moreover, there is now a body of evidence from human studies associating the composition and function of the gut microbiota with functional readouts of vaccine-induced immunity. For example, taxa such as <italic toggle="yes">Bifidobacterium</italic> are consistently associated with enhanced antibody responses across different vaccine types. These data are largely from observational studies, and further longitudinal and interventional studies are needed, for example, deploying dietary interventions or microbially targeted therapeutics alongside vaccination in the appropriate setting. Dysbiosis induced by antibiotics or dietary changes may disrupt immune responses and alter the immune cell composition, especially in early life. Thus, greater awareness is also needed of the potential negative impact of antibiotics on vaccine responses, emphasizing the importance of antibiotic stewardship around the time of immunizations, particularly in children.</p></sec></body><back><ack><title>Acknowledgments</title><p>The Division of Digestive Diseases receives financial support from the National Institute of Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London.</p></ack><sec sec-type="COI-statement" disp-level="1" id="s0006"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec sec-type="data-availability" disp-level="1" id="s0007"><title>Data availability statement</title><p>Data sharing is not applicable to this article as no new data were created or analyzed in this study.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Oxford Vaccine Group. The University of Oxford</collab></person-group>. <source>Measles</source>. [<date-in-citation>Accessed 2025 <month>Jan</month><day>20</day></date-in-citation>]. <ext-link xlink:href="https://vaccineknowledge.ox.ac.uk/measles#More-information" ext-link-type="uri">https://vaccineknowledge.ox.ac.uk/measles#More-information</ext-link>.</mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shattock</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Sim</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Carter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lambach</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hutubessy</surname><given-names>RCW</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Badizadegan</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lambert</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Ferrari</surname><given-names>MJ</given-names></string-name>, et al</person-group>. <article-title>Contribution of vaccination to improved survival and health: modelling 50 years of the expanded programme on immunization</article-title>. <source>The Lancet (Br ed)</source>. <year>2024</year>;<volume>403</volume>(<issue>10441</issue>):<fpage>2307</fpage>&#8211;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(24)00850-X</pub-id>.<pub-id pub-id-type="pmcid">PMC11140691</pub-id><pub-id pub-id-type="pmid">38705159</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ura</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Takeuchi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kawagoe</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Mizuki</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Okuda</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Shimada</surname><given-names>M.</given-names></string-name></person-group><article-title>Current vaccine platforms in enhancing T-cell response</article-title>. <source>Nato Adv Sci Inst Se</source>. <year>2022</year>;<volume>10</volume>(<issue>8</issue>):<fpage>1367</fpage>. doi: <pub-id pub-id-type="doi">10.3390/vaccines10081367</pub-id>.<pub-id pub-id-type="pmcid">PMC9413345</pub-id><pub-id pub-id-type="pmid">36016254</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mallajosyula</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Ganjavi</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chakraborty</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>McSween</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Pavlovitch-Bedzyk</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Wilhelmy</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nau</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Manohar</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nadeau</surname><given-names>KC</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>MM</given-names></string-name></person-group>. <article-title>Cd8 + T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19</article-title>. <source>Sci Immunol</source>. <year>2021</year>;<volume>6</volume>(<issue>61</issue>). doi: <pub-id pub-id-type="doi">10.1126/sciimmunol.abg5669</pub-id>.<pub-id pub-id-type="pmcid">PMC8975171</pub-id><pub-id pub-id-type="pmid">34210785</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Loyal</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Braun</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Henze</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kruse</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Dingeldey</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Reimer</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Kern</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Schwarz</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Mangold</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Unger</surname><given-names>C</given-names></string-name>, et al</person-group>. <article-title>Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination</article-title>. <source>Science</source>. <year>2021</year>;<volume>374</volume>(<issue>6564</issue>):<fpage>eabh1823</fpage>. doi: <pub-id pub-id-type="doi">10.1126/science.abh1823</pub-id>.<pub-id pub-id-type="pmid">34465633</pub-id><pub-id pub-id-type="pmcid">PMC10026850</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kumar</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kolls</surname><given-names>JK</given-names></string-name></person-group>. <article-title>Th17 cell based vaccines in mucosal immunity</article-title>. <source>Curr Opin Immunol</source>. <year>2013</year>;<volume>25</volume>(<issue>3</issue>):<fpage>373</fpage>&#8211;<lpage>380</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.coi.2013.03.011</pub-id>.<pub-id pub-id-type="pmid">23669353</pub-id><pub-id pub-id-type="pmcid">PMC3721632</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Batista-Duharte</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pera</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ali&#241;o</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Solana</surname><given-names>R</given-names></string-name></person-group>. <article-title>Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects</article-title>. <source>Int Immunopharmacol</source>. <year>2021</year>;<volume>96</volume>:<fpage>107761</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.intimp.2021.107761</pub-id>.<pub-id pub-id-type="pmid">34162139</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Luo</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>Q</given-names></string-name></person-group>. <article-title>B cell response to vaccination</article-title>. <source>Immunol Invest</source>. <year>2021</year>;<volume>50</volume>(<issue>7</issue>):<fpage>780</fpage>&#8211;<lpage>801</lpage>. doi: <pub-id pub-id-type="doi">10.1080/08820139.2021.1903033</pub-id>.<pub-id pub-id-type="pmid">33779464</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ali</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bhattacharyya</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ahmad</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Tiwari</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Jain</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Baad</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tiwari</surname><given-names>HD</given-names></string-name></person-group>. <article-title>Covid infections breakthrough post-vaccination: systematic review</article-title>. <source>J Educ Chang Pharmacy &amp; Bioallied Science</source>. <year>2022</year>;<volume>14</volume>(<issue>5</issue>):<fpage>196</fpage>&#8211;<lpage>199</lpage>. doi: <pub-id pub-id-type="doi">10.4103/jpbs.jpbs_132_22</pub-id>.<pub-id pub-id-type="pmcid">PMC9469404</pub-id><pub-id pub-id-type="pmid">36110618</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ta</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Soroush</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rogers</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>JH</given-names></string-name></person-group>. <article-title>A retrospective analysis of COVID-19 mRNA vaccine breakthrough infections - risk factors and vaccine effectiveness</article-title>. <source>medRxiv</source>. <year>2021</year>; doi: <pub-id pub-id-type="doi">10.1101/2021.10.05.21264583</pub-id>.</mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nair</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Gans</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Lew-Yasukawa</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Long-Wagar</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Arvin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Griffin</surname><given-names>DE</given-names></string-name></person-group>. <article-title>Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life</article-title>. <source>The J Infect Dis</source>. <year>2007</year>;<volume>196</volume>(<issue>9</issue>):<fpage>1339</fpage>&#8211;<lpage>1345</lpage>. doi: <pub-id pub-id-type="doi">10.1086/522519</pub-id>.<pub-id pub-id-type="pmid">17922398</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bolotovski</surname><given-names>VM</given-names></string-name>, <string-name name-style="western"><surname>Grabowsky</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Clements</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Albrecht</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Brenner</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Zargaryantzs</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Litvinov</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Mikheyeva</surname><given-names>IV</given-names></string-name></person-group>. <article-title>Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine</article-title>. <source>Int J Epidemiol</source>. <year>1994</year>;<volume>23</volume>(<issue>5</issue>):<fpage>1069</fpage>&#8211;<lpage>1077</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ije/23.5.1069</pub-id>.<pub-id pub-id-type="pmid">7860158</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Del Giudice</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Weinberger</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Grubeck-Loebenstein</surname><given-names>B</given-names></string-name></person-group>. <article-title>Vaccines for the elderly</article-title>. <source>Gerontology (Basel)</source>. <year>2015</year>;<volume>61</volume>(<issue>3</issue>):<fpage>203</fpage>&#8211;<lpage>210</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000366162</pub-id>.<pub-id pub-id-type="pmid">25402229</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Anticoli</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Capanna</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Volpin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Melis</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ortona</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Vonesch</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Tomao</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Scapellato</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Ruggieri</surname><given-names>A</given-names></string-name></person-group>. <article-title>Sex differences in response to HBV vaccination in a cohort of health care workers</article-title>. <source>Vaccine</source>. <year>2025</year>;<volume>22</volume>:<fpage>100605</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jvacx.2024.100605</pub-id>.<pub-id pub-id-type="pmcid">PMC11731748</pub-id><pub-id pub-id-type="pmid">39811673</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cooling</surname><given-names>L</given-names></string-name></person-group>. <article-title>Blood groups in infection and host susceptibility</article-title>. <source>Clin Microbiol Rev</source>. <year>2015</year>;<volume>28</volume>(<issue>3</issue>):<fpage>801</fpage>&#8211;<lpage>870</lpage>. doi: <pub-id pub-id-type="doi">10.1128/cmr.00109-14</pub-id>.<pub-id pub-id-type="pmid">26085552</pub-id><pub-id pub-id-type="pmcid">PMC4475644</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Opri</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Veneri</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Mengoli</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Zanoni</surname><given-names>G</given-names></string-name></person-group>. <article-title>Immune response to hepatitis B vaccine in patients with celiac disease: a systematic review and meta-analysis</article-title>. <source>Hum Vaccines &amp; Immunotherapeutics</source>. <year>2015</year>;<volume>11</volume>(<issue>12</issue>):<fpage>2800</fpage>&#8211;<lpage>2805</lpage>. doi: <pub-id pub-id-type="doi">10.1080/21645515.2015.1069448</pub-id>.<pub-id pub-id-type="pmcid">PMC5054794</pub-id><pub-id pub-id-type="pmid">26378476</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zheng</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Liwinski</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Elinav</surname><given-names>E</given-names></string-name></person-group>. <article-title>Interaction between microbiota and immunity in health and disease</article-title>. <source>Cell Res</source>. <year>2020</year>;<volume>30</volume>(<issue>6</issue>):<fpage>492</fpage>&#8211;<lpage>506</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41422-020-0332-7</pub-id>.<pub-id pub-id-type="pmid">32433595</pub-id><pub-id pub-id-type="pmcid">PMC7264227</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>E</given-names></string-name></person-group>. <article-title>The role of gut microbiota in immune homeostasis and autoimmunity</article-title>. <source>Gut Microbes</source>. <year>2012</year>;<volume>3</volume>(<issue>1</issue>):<fpage>4</fpage>&#8211;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.4161/gmic.19320</pub-id>.<pub-id pub-id-type="pmid">22356853</pub-id><pub-id pub-id-type="pmcid">PMC3337124</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>G</given-names></string-name></person-group>. <article-title>Cancer immunotherapy: fecal microbiota transplantation brings light</article-title>. <source>Curr Treat Options In Oncol</source>. <year>2022</year>;<volume>23</volume>(<issue>12</issue>):<fpage>1777</fpage>&#8211;<lpage>1792</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11864-022-01027-2</pub-id>.<pub-id pub-id-type="pmcid">PMC9589549</pub-id><pub-id pub-id-type="pmid">36279081</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bertolini</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Fiorotto</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Strazzabosco</surname><given-names>M</given-names></string-name></person-group>. <article-title>Bile acids and their receptors: modulators and therapeutic targets in liver inflammation</article-title>. <source>Semin Immunopathol</source>. <year>2022</year>;<volume>44</volume>(<issue>4</issue>):<fpage>547</fpage>&#8211;<lpage>564</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00281-022-00935-7</pub-id>.<pub-id pub-id-type="pmid">35415765</pub-id><pub-id pub-id-type="pmcid">PMC9256560</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Z</given-names></string-name>, et al</person-group>. <article-title>Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells&#8217; differentiation and function in induction of colitis</article-title>. <source>Inflamm Bowel Dis</source>. <year>2019</year>;<volume>25</volume>(<issue>9</issue>):<fpage>1450</fpage>&#8211;<lpage>1461</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ibd/izz046</pub-id>.<pub-id pub-id-type="pmid">30918945</pub-id><pub-id pub-id-type="pmcid">PMC6701512</pub-id></mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mann</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>YK</given-names></string-name>, <string-name name-style="western"><surname>Uhlig</surname><given-names>HH</given-names></string-name></person-group>. <article-title>Short-chain fatty acids: linking diet, the microbiome and immunity</article-title>. <source>Nat Rev Immunol</source>. <year>2024</year>;<volume>24</volume>(<issue>8</issue>):<fpage>577</fpage>&#8211;<lpage>595</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41577-024-01014-8</pub-id>.<pub-id pub-id-type="pmid">38565643</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Godlewska</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Bulanda</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Wypych</surname><given-names>TP</given-names></string-name></person-group>. <article-title>Bile acids in immunity: bidirectional mediators between the host and the microbiota</article-title>. <source>Front Immunol</source>. <year>2022</year>;<volume>13</volume>:<fpage>949033</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.949033</pub-id>.<pub-id pub-id-type="pmid">36052074</pub-id><pub-id pub-id-type="pmcid">PMC9425027</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lynn</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Benson</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Lynn</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Pulendran</surname><given-names>B</given-names></string-name></person-group>. <article-title>Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms</article-title>. <source>Nat Rev Immunol</source>. <year>2022</year>;<volume>22</volume>(<issue>1</issue>):<fpage>33</fpage>&#8211;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41577-021-00554-7</pub-id>.<pub-id pub-id-type="pmid">34002068</pub-id><pub-id pub-id-type="pmcid">PMC8127454</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>de Jong</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Olin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pulendran</surname><given-names>B</given-names></string-name></person-group>. <article-title>The impact of the microbiome on immunity to vaccination in humans</article-title>. <source>Cell Host &amp; Microbe</source>. <year>2020</year>;<volume>28</volume>(<issue>2</issue>):<fpage>169</fpage>&#8211;<lpage>179</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2020.06.014</pub-id>.<pub-id pub-id-type="pmid">32791110</pub-id><pub-id pub-id-type="pmcid">PMC7422826</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hong</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Yuan</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>W</given-names></string-name></person-group>. <article-title>A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines</article-title>. <source>Gut Microbes</source>. <year>2023</year>;<volume>15</volume>(<issue>1</issue>):<fpage>2233146</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2023.2233146</pub-id>.<pub-id pub-id-type="pmid">37431857</pub-id><pub-id pub-id-type="pmcid">PMC10337507</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ardura-Garcia</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Curtis</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Zimmermann</surname><given-names>P</given-names></string-name></person-group>. <article-title>Systematic review of the impact of intestinal microbiota on vaccine responses</article-title>. <source>npj Vaccines</source>. <year>2024</year>;<volume>9</volume>(<issue>1</issue>):<fpage>254</fpage>&#8211;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41541-024-01000-0</pub-id>.<pub-id pub-id-type="pmid">39706841</pub-id><pub-id pub-id-type="pmcid">PMC11662010</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ng</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Mok</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ching</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>DLS</given-names></string-name>, et al</person-group>. <article-title>Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events</article-title>. <source>Gut</source>. <year>2022</year>;<volume>71</volume>(<issue>6</issue>):<fpage>1106</fpage>&#8211;<lpage>1116</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2021-326563</pub-id>.<pub-id pub-id-type="pmid">35140064</pub-id><pub-id pub-id-type="pmcid">PMC8844967</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jia</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Weng</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Tian</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Fang</surname><given-names>F</given-names></string-name>, et al</person-group>. <article-title>Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity</article-title>. <source>Gut Microbes</source>. <year>2022</year>;<volume>14</volume>(<issue>1</issue>):<fpage>2117503</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2022.2117503</pub-id>.<pub-id pub-id-type="pmid">36100957</pub-id><pub-id pub-id-type="pmcid">PMC9481142</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Han</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Gui</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>W</given-names></string-name>, et al</person-group>. <article-title>Dynamic changes in host immune system and gut microbiota are associated with the production of SARS-CoV-2 antibodies</article-title>. <source>Gut</source>. <year>2023</year>;<volume>72</volume>(<issue>10</issue>):<fpage>1996</fpage>&#8211;<lpage>1999</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2022-327561</pub-id>.<pub-id pub-id-type="pmid">36207022</pub-id><pub-id pub-id-type="pmcid">PMC10511961</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tang</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Pang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lei</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, et al</person-group>. <article-title>Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP-CorV vaccine</article-title>. <source>Cell Reports Med</source>. <year>2022</year>;<volume>3</volume>(<issue>10</issue>):<fpage>100752</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.xcrm.2022.100752</pub-id>.<pub-id pub-id-type="pmcid">PMC9589008</pub-id><pub-id pub-id-type="pmid">36228621</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alexander</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Mullish</surname><given-names>BH</given-names></string-name>, <string-name name-style="western"><surname>Danckert</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Olbei</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Saifuddin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Torkizadeh</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ibraheim</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Blanco</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>LA</given-names></string-name>, et al</person-group>. <article-title>The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients</article-title>. <source>EBioMedicine</source>. <year>2023</year>;<volume>88</volume>:<fpage>104430</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ebiom.2022.104430</pub-id>.<pub-id pub-id-type="pmid">36634565</pub-id><pub-id pub-id-type="pmcid">PMC9831064</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hirota</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tamai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yukawa</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Taira</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Matthews</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Toma</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Seto</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Toguchi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Miyagi</surname><given-names>M</given-names></string-name>, et al</person-group>. <article-title>Human immune and gut microbial parameters associated with inter-individual variations in COVID-19 mRNA vaccine-induced immunity</article-title>. <source>Commun Biol</source>. <year>2023</year>;<volume>6</volume>(<issue>1</issue>):<fpage>368</fpage>&#8211;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s42003-023-04755-9</pub-id>.<pub-id pub-id-type="pmid">37081096</pub-id><pub-id pub-id-type="pmcid">PMC10119155</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Daddi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Dorsett</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Geng</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bokoliya</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yuan</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Baseline gut microbiome signatures correlate with immunogenicity of SARS-CoV-2 mRNA vaccines</article-title>. <source>Int J Mol Sci</source>. <year>2023</year>;<volume>24</volume>(<issue>14</issue>):<fpage>11703</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms241411703</pub-id>.<pub-id pub-id-type="pmid">37511464</pub-id><pub-id pub-id-type="pmcid">PMC10380288</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Peng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Mok</surname><given-names>CKP</given-names></string-name>, <string-name name-style="western"><surname>Ching</surname><given-names>JYL</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>MKL</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>S</given-names></string-name>, et al</person-group>. <article-title>Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines</article-title>. <source>Sig Transduct Target Ther</source>. <year>2023</year>;<volume>8</volume>(<issue>1</issue>):<fpage>373</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-023-01629-8</pub-id>.<pub-id pub-id-type="pmcid">PMC10518331</pub-id><pub-id pub-id-type="pmid">37743379</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lunken</surname><given-names>GR</given-names></string-name>, <string-name name-style="western"><surname>Golding</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Schick</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Majdoubi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lavoie</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Vallance</surname><given-names>BA</given-names></string-name></person-group>. <article-title>Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS-CoV-2 mRNA vaccination</article-title>. <source>Gut</source>. <year>2024</year>;<volume>73</volume>(<issue>1</issue>):<fpage>1.1</fpage>&#8211;<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2022-328556</pub-id>.<pub-id pub-id-type="pmcid">PMC10715502</pub-id><pub-id pub-id-type="pmid">36549875</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ray</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Narayanan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Vesterbacka</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Blennow</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Gabarrini</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Ljunggren</surname><given-names>H-G</given-names></string-name>, <string-name name-style="western"><surname>Buggert</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Manoharan</surname><given-names>L</given-names></string-name>, et al</person-group>. <article-title>Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV</article-title>. <source>NPJ Biofilms Microbiomes</source>. <year>2023</year>;<volume>9</volume>(<issue>1</issue>):<fpage>104</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41522-023-00461-w</pub-id>.<pub-id pub-id-type="pmid">38123600</pub-id><pub-id pub-id-type="pmcid">PMC10733305</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Seong</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yoon</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Nham</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Choi</surname><given-names>YJ</given-names></string-name>, <string-name name-style="western"><surname>Noh</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Cheong</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>EH</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>Y-H</given-names></string-name>, et al</person-group>. <article-title>The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination</article-title>. <source>J Transl Med</source>. <year>2024</year>;<volume>22</volume>(<issue>1</issue>):<fpage>827</fpage>&#8211;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12967-024-05637-2</pub-id>.<pub-id pub-id-type="pmid">39242525</pub-id><pub-id pub-id-type="pmcid">PMC11380214</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ng</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Liao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Cheung</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>KH</given-names></string-name>, <string-name name-style="western"><surname>Seto</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>WK</given-names></string-name>, <string-name name-style="western"><surname>Hung</surname><given-names>IFN</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>TTY</given-names></string-name>, <string-name name-style="western"><surname>Cheung</surname><given-names>KS</given-names></string-name></person-group>. <article-title>Gut microbiota is associated with persistence of longer-term BNT162b2 vaccine immunogenicity</article-title>. <source>Front Immunol</source>. <year>2025</year>;<volume>16</volume>:<fpage>1534787</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2025.1534787</pub-id>.<pub-id pub-id-type="pmid">40083550</pub-id><pub-id pub-id-type="pmcid">PMC11903479</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huda</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Lewis</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Kalanetra</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Rashid</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ahmad</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Raqib</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Qadri</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Underwood</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Mills</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Stephensen</surname><given-names>CB</given-names></string-name></person-group>. <article-title>Stool microbiota and vaccine responses of infants</article-title>. <source>Pediatrics</source>. <year>2014</year>;<volume>134</volume>(<issue>2</issue>):<fpage>e362</fpage>&#8211;<lpage>e372</lpage>. doi: <pub-id pub-id-type="doi">10.1542/peds.2013-3937</pub-id>.<pub-id pub-id-type="pmid">25002669</pub-id><pub-id pub-id-type="pmcid">PMC4187229</pub-id></mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huda</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Ahmad</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Alam</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Khanam</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kalanetra</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Taft</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Raqib</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Underwood</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Mills</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Stephensen</surname><given-names>CB</given-names></string-name></person-group>. <article-title>Bifidobacterium abundance in early infancy and vaccine response at 2 years of age</article-title>. <source>Pediatrics</source>. <year>2019</year>;<volume>143</volume>(<issue>2</issue>):<fpage>e20</fpage>. doi: <pub-id pub-id-type="doi">10.1542/peds.2018-1489</pub-id>.<pub-id pub-id-type="pmcid">PMC6361348</pub-id><pub-id pub-id-type="pmid">30674610</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moroishi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Gui</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nadeau</surname><given-names>KC</given-names></string-name>, <string-name name-style="western"><surname>Morrison</surname><given-names>HG</given-names></string-name>, <string-name name-style="western"><surname>Madan</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Karagas</surname><given-names>MR</given-names></string-name></person-group>. <article-title>A prospective study of the infant gut microbiome in relation to vaccine response</article-title>. <source>Pediatr Res</source>. <year>2023</year>;<volume>93</volume>(<issue>3</issue>):<fpage>725</fpage>&#8211;<lpage>731</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41390-022-02154-0</pub-id>.<pub-id pub-id-type="pmid">35717483</pub-id><pub-id pub-id-type="pmcid">PMC10115145</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ryan</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Clarke</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lynn</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Benson</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>McAlister</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Giles</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Choo</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Rossouw</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ng</surname><given-names>YY</given-names></string-name>, <string-name name-style="western"><surname>Semchenko</surname><given-names>EA</given-names></string-name>, et al</person-group>. <article-title>Bifidobacteria support optimal infant vaccine responses</article-title>. <source>Nat (Lond)</source>. <year>2025</year>;<volume>641</volume>(<issue>8062</issue>):<fpage>456</fpage>&#8211;<lpage>464</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-025-08796-4</pub-id>.<pub-id pub-id-type="pmid">40175554</pub-id><pub-id pub-id-type="pmcid">PMC12058517</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nowak</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Troseid</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Avershina</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Barqasho</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Neogi</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Holm</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hov</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Noyan</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Vesterbacka</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sv&#228;rd</surname><given-names>J</given-names></string-name>, et al</person-group>. <article-title>Gut microbiota diversity predicts immune status in HIV-1 infection</article-title>. <source>AIDS (Lond)</source>. <year>2015</year>;<volume>29</volume>(<issue>18</issue>):<fpage>2409</fpage>&#8211;<lpage>2418</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QAD.0000000000000869</pub-id>.<pub-id pub-id-type="pmid">26355675</pub-id></mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ray</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Narayanan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Giske</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>Neogi</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Sonnerborg</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nowak</surname><given-names>P</given-names></string-name></person-group>. <article-title>Altered gut microbiome under antiretroviral therapy: impact of efavirenz and zidovudine</article-title>. <source>ACS Infect Dis</source>. <year>2021</year>;<volume>7</volume>(<issue>5</issue>):<fpage>1104</fpage>&#8211;<lpage>1115</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00536</pub-id>.<pub-id pub-id-type="pmid">33346662</pub-id><pub-id pub-id-type="pmcid">PMC8154435</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zevin</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>McKinnon</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Burgener</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Klatt</surname><given-names>NR</given-names></string-name></person-group>. <article-title>Microbial translocation and microbiome dysbiosis in HIV-associated immune activation</article-title>. <source>Curr Opin HIV AIDS</source>. <year>2016</year>;<volume>11</volume>(<issue>2</issue>):<fpage>182</fpage>&#8211;<lpage>190</lpage>. doi: <pub-id pub-id-type="doi">10.1097/COH.0000000000000234</pub-id>.<pub-id pub-id-type="pmid">26679414</pub-id><pub-id pub-id-type="pmcid">PMC4752849</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Deeke</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Ning</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Starr</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Butcher</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mayne</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Liao</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name>, et al</person-group>. <article-title>Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease</article-title>. <source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>2873</fpage>&#8211;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-018-05357-4</pub-id>.<pub-id pub-id-type="pmid">30030445</pub-id><pub-id pub-id-type="pmcid">PMC6054643</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Iljazovic</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Roy</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>G&#225;lvez</surname><given-names>EJC</given-names></string-name>, <string-name name-style="western"><surname>Lesker</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Gronow</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Amend</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Will</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Hofmann</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Pils</surname><given-names>MC</given-names></string-name>, et al</person-group>. <article-title>Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation</article-title>. <source>Mucosal Immunol</source>. <year>2021</year>;<volume>14</volume>(<issue>1</issue>):<fpage>113</fpage>&#8211;<lpage>124</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41385-020-0296-4</pub-id>.<pub-id pub-id-type="pmid">32433514</pub-id><pub-id pub-id-type="pmcid">PMC7790746</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Qian</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Ji</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>C-Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>A-Q</given-names></string-name></person-group>. <article-title>Integrated microbiome, metabolome, and proteome analysis identifies a novel interplay among commensal bacteria, metabolites and candidate targets in non&#8208;small cell lung cancer</article-title>. <source>Clin &amp; Transl Med</source>. <year>2022</year>;<volume>12</volume>(<issue>6</issue>):<fpage>e947</fpage>&#8211;<lpage>n/a</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ctm2.947</pub-id>.<pub-id pub-id-type="pmid">35735103</pub-id><pub-id pub-id-type="pmcid">PMC9218934</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Scher</surname><given-names>JU</given-names></string-name>, <string-name name-style="western"><surname>Sczesnak</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Longman</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Segata</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Ubeda</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bielski</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rostron</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Cerundolo</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Pamer</surname><given-names>EG</given-names></string-name>, <string-name name-style="western"><surname>Abramson</surname><given-names>SB</given-names></string-name>, et al</person-group>. <article-title>Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis</article-title>. <source>eLife</source>. <year>2013</year>;<volume>2</volume>(<issue>e01202</issue>). doi: <pub-id pub-id-type="doi">10.7554/eLife.01202</pub-id>.<pub-id pub-id-type="pmcid">PMC3816614</pub-id><pub-id pub-id-type="pmid">24192039</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dillon</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Kotter</surname><given-names>CV</given-names></string-name>, <string-name name-style="western"><surname>Austin</surname><given-names>GL</given-names></string-name>, <string-name name-style="western"><surname>Gianella</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Siewe</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Landay</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>McManus</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Robertson</surname><given-names>CE</given-names></string-name>, et al</person-group>. <article-title>Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection</article-title>. <source>Mucosal Immunol</source>. <year>2016</year>;<volume>9</volume>(<issue>1</issue>):<fpage>24</fpage>&#8211;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mi.2015.33</pub-id>.<pub-id pub-id-type="pmid">25921339</pub-id><pub-id pub-id-type="pmcid">PMC4626441</pub-id></mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Maldonado-Contreras</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ferrer</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cawley</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Crain</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bhattarai</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Toscano</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>DV</given-names></string-name>, <string-name name-style="western"><surname>Hoffman</surname><given-names>A</given-names></string-name></person-group>. <article-title>Dysbiosis in a canine model of human fistulizing Crohn&#8217;s disease</article-title>. <source>Gut Microbes</source>. <year>2020</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1785246</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2020.1785246</pub-id>.<pub-id pub-id-type="pmid">32730134</pub-id><pub-id pub-id-type="pmcid">PMC7524328</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Obuya</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Elkholy</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Avuthu</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Behring</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bajpai</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Agarwal</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>H-G</given-names></string-name>, <string-name name-style="western"><surname>El-Nikhely</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Akinyi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Orwa</surname><given-names>J</given-names></string-name>, et al</person-group>. <article-title>A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients</article-title>. <source>J Gastrointest Oncol</source>. <year>2022</year>;<volume>13</volume>(<issue>5</issue>):<fpage>2282</fpage>&#8211;<lpage>2292</lpage>. doi: <pub-id pub-id-type="doi">10.21037/jgo-22-116</pub-id>.<pub-id pub-id-type="pmid">36388691</pub-id><pub-id pub-id-type="pmcid">PMC9660062</pub-id></mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lankelma</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>van Vught</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Belzer</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Schultz</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>van der Poll</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>de Vos</surname><given-names>WM</given-names></string-name>, <string-name name-style="western"><surname>Wiersinga</surname><given-names>WJ</given-names></string-name></person-group>. <article-title>Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study</article-title>. <source>Intensive Care Med</source>. <year>2017</year>;<volume>43</volume>(<issue>1</issue>):<fpage>59</fpage>&#8211;<lpage>68</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00134-016-4613-z</pub-id>.<pub-id pub-id-type="pmid">27837233</pub-id><pub-id pub-id-type="pmcid">PMC5203863</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Borey</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Blanc</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Lemonnier</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Leplat</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jardet</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rossignol</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ravon</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Billon</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Bernard</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Estell&#233;</surname><given-names>J</given-names></string-name>, et al</person-group>. <article-title>Links between fecal microbiota and the response to vaccination against influenza A virus in pigs</article-title>. <source>npj Vaccines</source>. <year>2021</year>;<volume>6</volume>(<issue>1</issue>):<fpage>92</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41541-021-00351-2</pub-id>.<pub-id pub-id-type="pmid">34294732</pub-id><pub-id pub-id-type="pmcid">PMC8298503</pub-id></mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hagan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Cortese</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rouphael</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Boudreau</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Linde</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Maddur</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Das</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Guthmiller</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>N-Y</given-names></string-name>, et al</person-group>. <article-title>Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans</article-title>. <source>Cell</source>. <year>2019</year>;<volume>178</volume>(<issue>6</issue>):<fpage>1313</fpage>&#8211;<lpage>1328.e13</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2019.08.010</pub-id>.<pub-id pub-id-type="pmid">31491384</pub-id><pub-id pub-id-type="pmcid">PMC6750738</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cheung</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ooi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>To</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Hui</surname><given-names>C-H</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>K-H</given-names></string-name>, <string-name name-style="western"><surname>Seto</surname><given-names>W-K</given-names></string-name>, <string-name name-style="western"><surname>Hung</surname><given-names>IFN</given-names></string-name>, et al</person-group>. <article-title>Association between recent usage of antibiotics and immunogenicity within six months after COVID-19 vaccination</article-title>. <source>Nato Adv Sci Inst Se</source>. <year>2022</year>;<volume>10</volume>(<issue>7</issue>):<fpage>1122</fpage>. doi: <pub-id pub-id-type="doi">10.3390/vaccines10071122</pub-id>.<pub-id pub-id-type="pmcid">PMC9318721</pub-id><pub-id pub-id-type="pmid">35891286</pub-id></mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Subramanian</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Huq</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yatsunenko</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Haque</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Mahfuz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Alam</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Benezra</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>DeStefano</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Meier</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Muegge</surname><given-names>BD</given-names></string-name>, et al</person-group>. <article-title>Persistent gut microbiota immaturity in malnourished Bangladeshi children</article-title>. <source>Nature</source>. <year>2014</year>;<volume>510</volume>(<issue>7505</issue>):<fpage>417</fpage>&#8211;<lpage>421</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature13421</pub-id>.<pub-id pub-id-type="pmid">24896187</pub-id><pub-id pub-id-type="pmcid">PMC4189846</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>De Filippo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Cavalieri</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Di Paola</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ramazzotti</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Poullet</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Massart</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Collini</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Pieraccini</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lionetti</surname><given-names>P</given-names></string-name></person-group>. <article-title>Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2010</year>;<volume>107</volume>(<issue>33</issue>):<fpage>14691</fpage>&#8211;<lpage>14696</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1005963107</pub-id>.<pub-id pub-id-type="pmid">20679230</pub-id><pub-id pub-id-type="pmcid">PMC2930426</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rothschild</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Weissbrod</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Barkan</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Kurilshikov</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Korem</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Zeevi</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Costea</surname><given-names>PI</given-names></string-name>, <string-name name-style="western"><surname>Godneva</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kalka</surname><given-names>IN</given-names></string-name>, <string-name name-style="western"><surname>Bar</surname><given-names>N</given-names></string-name>, et al</person-group>. <article-title>Environment dominates over host genetics in shaping human gut microbiota</article-title>. <source>Nat (Lond)</source>. <year>2018</year>;<volume>555</volume>(<issue>7695</issue>):<fpage>210</fpage>&#8211;<lpage>215</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature25973</pub-id>.<pub-id pub-id-type="pmid">29489753</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>B&#228;ckhed</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Roswall</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kovatcheva-Datchary</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xia</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zhong</surname><given-names>H</given-names></string-name>, et al</person-group>. <article-title>Dynamics and stabilization of the human gut microbiome during the first year of life</article-title>. <source>Cell Host &amp; Microbe</source>. <year>2015</year>;<volume>17</volume>(<issue>6</issue>):<fpage>852</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2015.05.012</pub-id>.<pub-id pub-id-type="pmid">26308884</pub-id></mixed-citation></ref><ref id="cit0062"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>DeJong</surname><given-names>EN</given-names></string-name>, <string-name name-style="western"><surname>Surette</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Bowdish</surname><given-names>DME</given-names></string-name></person-group>. <article-title>The gut microbiota and unhealthy aging: disentangling cause from consequence</article-title>. <source>Cell Host &amp; Microbe</source>. <year>2020</year>;<volume>28</volume>(<issue>2</issue>):<fpage>180</fpage>&#8211;<lpage>189</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2020.07.013</pub-id>.<pub-id pub-id-type="pmid">32791111</pub-id></mixed-citation></ref><ref id="cit0063"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Qie</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>C</given-names></string-name></person-group>. <article-title>Gut microbial metabolites fuel host antibody responses</article-title>. <source>Cell Host &amp; Microbe</source>. <year>2016</year>;<volume>20</volume>(<issue>2</issue>):<fpage>202</fpage>&#8211;<lpage>214</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2016.07.001</pub-id>.<pub-id pub-id-type="pmid">27476413</pub-id><pub-id pub-id-type="pmcid">PMC4982788</pub-id></mixed-citation></ref><ref id="cit0064"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sun</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>J</given-names></string-name></person-group>. <article-title>Butyrate as a promising therapeutic target in cancer: from pathogenesis to clinic (review)</article-title>. <source>Int J Oncol</source>. <year>2024</year>;<volume>64</volume>(<issue>4</issue>):<fpage>1</fpage>. doi: <pub-id pub-id-type="doi">10.3892/ijo.2024.5632</pub-id>.<pub-id pub-id-type="pmid">38426581</pub-id><pub-id pub-id-type="pmcid">PMC10919761</pub-id></mixed-citation></ref><ref id="cit0065"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mazmanian</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Tzianabos</surname><given-names>AO</given-names></string-name>, <string-name name-style="western"><surname>Kasper</surname><given-names>DL</given-names></string-name></person-group>. <article-title>An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system</article-title>. <source>Cell</source>. <year>2005</year>;<volume>122</volume>(<issue>1</issue>):<fpage>107</fpage>&#8211;<lpage>118</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2005.05.007</pub-id>.<pub-id pub-id-type="pmid">16009137</pub-id></mixed-citation></ref><ref id="cit0066"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ivanov</surname><given-names>II</given-names></string-name>, <string-name name-style="western"><surname>Frutos</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Manel</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Yoshinaga</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Rifkin</surname><given-names>DB</given-names></string-name>, <string-name name-style="western"><surname>Sartor</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Finlay</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Littman</surname><given-names>DR</given-names></string-name></person-group>. <article-title>Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine</article-title>. <source>Cell Host &amp; Microbe</source>. <year>2008</year>;<volume>4</volume>(<issue>4</issue>):<fpage>337</fpage>&#8211;<lpage>349</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2008.09.009</pub-id>.<pub-id pub-id-type="pmid">18854238</pub-id><pub-id pub-id-type="pmcid">PMC2597589</pub-id></mixed-citation></ref><ref id="cit0067"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Park</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>Jannasch</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Cooper</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Patterson</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>CH</given-names></string-name></person-group>. <article-title>Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR&#8211;S6K pathway</article-title>. <source>Mucosal Immunol</source>. <year>2015</year>;<volume>8</volume>(<issue>1</issue>):<fpage>80</fpage>&#8211;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mi.2014.44</pub-id>.<pub-id pub-id-type="pmid">24917457</pub-id><pub-id pub-id-type="pmcid">PMC4263689</pub-id></mixed-citation></ref><ref id="cit0068"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Shen</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wei</surname><given-names>Y-Q</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>CK</given-names></string-name></person-group>. <article-title>Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>(<issue>1</issue>):<fpage>24249</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep24249</pub-id>.<pub-id pub-id-type="pmid">27075020</pub-id><pub-id pub-id-type="pmcid">PMC4831052</pub-id></mixed-citation></ref><ref id="cit0069"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sepahi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Friesen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>CH</given-names></string-name></person-group>. <article-title>Dietary fiber metabolites regulate innate lymphoid cell responses</article-title>. <source>Mucosal Immunol</source>. <year>2021</year>;<volume>14</volume>(<issue>2</issue>):<fpage>317</fpage>&#8211;<lpage>330</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41385-020-0312-8</pub-id>.<pub-id pub-id-type="pmid">32541842</pub-id><pub-id pub-id-type="pmcid">PMC7736174</pub-id></mixed-citation></ref><ref id="cit0070"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jiang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Jing</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Q</given-names></string-name></person-group>. <article-title>Dietary fiber-derived microbial butyrate suppresses ILC2-dependent airway inflammation in COPD</article-title>. <source>Mediators Inflam</source>. <year>2024</year>;<volume>2024</volume>(<issue>1</issue>):<fpage>6263447</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2024/6263447</pub-id>.<pub-id pub-id-type="pmcid">PMC11251798</pub-id><pub-id pub-id-type="pmid">39015676</pub-id></mixed-citation></ref><ref id="cit0071"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Silver</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Kearley</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Copenhaver</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Sanden</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Mori</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Pritchard</surname><given-names>GH</given-names></string-name>, <string-name name-style="western"><surname>Berlin</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Hunter</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Bowler</surname><given-names>R</given-names></string-name>, et al</person-group>. <article-title>Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs</article-title>. <source>Nat Immunol</source>. <year>2016</year>;<volume>17</volume>(<issue>6</issue>):<fpage>626</fpage>&#8211;<lpage>635</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ni.3443</pub-id>.<pub-id pub-id-type="pmid">27111143</pub-id><pub-id pub-id-type="pmcid">PMC5345745</pub-id></mixed-citation></ref><ref id="cit0072"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Williams</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Roy</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Furuya</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Wijesundara</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Furuya</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Lung group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza</article-title>. <source>Clin &amp; Trans Imm</source>. <year>2022</year>;<volume>11</volume>(<issue>3</issue>):<fpage>e1381</fpage>&#8211;<lpage>n/a</lpage>. doi: <pub-id pub-id-type="doi">10.1002/cti2.1381</pub-id>.<pub-id pub-id-type="pmcid">PMC8958247</pub-id><pub-id pub-id-type="pmid">35356066</pub-id></mixed-citation></ref><ref id="cit0073"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ichinohe</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Pang</surname><given-names>IK</given-names></string-name>, <string-name name-style="western"><surname>Kumamoto</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Peaper</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Ho</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Murray</surname><given-names>TS</given-names></string-name>, <string-name name-style="western"><surname>Iwasaki</surname><given-names>A</given-names></string-name></person-group>. <article-title>Microbiota regulates immune defense against respiratory tract influenza A virus infection</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2011</year>;<volume>108</volume>(<issue>13</issue>):<fpage>5354</fpage>&#8211;<lpage>5359</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1019378108</pub-id>.<pub-id pub-id-type="pmid">21402903</pub-id><pub-id pub-id-type="pmcid">PMC3069176</pub-id></mixed-citation></ref><ref id="cit0074"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ross</surname><given-names>FC</given-names></string-name>, <string-name name-style="western"><surname>Patangia</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Grimaud</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lavelle</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Dempsey</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Ross</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Stanton</surname><given-names>C</given-names></string-name></person-group>. <article-title>The interplay between diet and the gut microbiome: implications for health and disease</article-title>. <source>Nat Rev Microbiol</source>. <year>2024</year>;<volume>22</volume>(<issue>11</issue>):<fpage>671</fpage>&#8211;<lpage>686</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41579-024-01068-4</pub-id>.<pub-id pub-id-type="pmid">39009882</pub-id></mixed-citation></ref><ref id="cit0075"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kihl</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Krych</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hansen</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Buschard</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Skov</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Nielsen</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Kornerup Hansen</surname><given-names>A</given-names></string-name></person-group>. <article-title>Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination</article-title>. <source>PLOS ONE</source>. <year>2022</year>;<volume>17</volume>(<issue>4</issue>):<fpage>e0266719</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0266719</pub-id>.<pub-id pub-id-type="pmid">35417506</pub-id><pub-id pub-id-type="pmcid">PMC9007335</pub-id></mixed-citation></ref><ref id="cit0076"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vangay</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Lucas</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Beura</surname><given-names>LK</given-names></string-name>, <string-name name-style="western"><surname>Sabas</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Abramson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Till</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hoops</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Kashyap</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hunter</surname><given-names>RC</given-names></string-name>, et al</person-group>. <article-title>Industrialized human gut microbiota increases CD8+ T cells and mucus thickness in humanized mouse gut</article-title>. <source>Gut Microbes</source>. <year>2023</year>;<volume>15</volume>(<issue>2</issue>):<fpage>2266627</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2023.2266627</pub-id>.<pub-id pub-id-type="pmid">37853762</pub-id><pub-id pub-id-type="pmcid">PMC10588527</pub-id></mixed-citation></ref><ref id="cit0077"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Honce</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Vazquez-Pagan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Livingston</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Mandarano</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Wilander</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Cherry</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hargest</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Sharp</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Brigleb</surname><given-names>PH</given-names></string-name>, <string-name name-style="western"><surname>Kirkpatrick Roubidoux</surname><given-names>E</given-names></string-name>, et al</person-group>. <article-title>Diet switch pre-vaccination improves immune response and metabolic status in formerly obese mice</article-title>. <source>Nat Microbiol</source>. <year>2024</year>;<volume>9</volume>(<issue>6</issue>):<fpage>1593</fpage>&#8211;<lpage>1606</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-024-01677-y</pub-id>.<pub-id pub-id-type="pmid">38637722</pub-id></mixed-citation></ref><ref id="cit0078"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Johnson</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Ardanuy</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hammond</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Logue</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Baracco</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>McGrath</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dillen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>G</given-names></string-name>, et al</person-group>. <article-title>Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2</article-title>. <source>J Virol</source>. <year>2023</year>;<volume>97</volume>(<issue>11</issue>):<fpage>e0133623</fpage>. doi: <pub-id pub-id-type="doi">10.1128/jvi.01336-23</pub-id>.<pub-id pub-id-type="pmid">37846985</pub-id><pub-id pub-id-type="pmcid">PMC10688338</pub-id></mixed-citation></ref><ref id="cit0079"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Miller</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Singer</surname><given-names>M</given-names></string-name></person-group>. <article-title>Do antibiotics cause mitochondrial and immune cell dysfunction? A literature review</article-title>. <source>The J Antimicrob Chemother</source>. <year>2022</year>;<volume>77</volume>(<issue>5</issue>):<fpage>1218</fpage>&#8211;<lpage>1227</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkac025</pub-id>.<pub-id pub-id-type="pmid">35211738</pub-id></mixed-citation></ref><ref id="cit0080"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Snow</surname><given-names>TAC</given-names></string-name>, <string-name name-style="western"><surname>Singer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Arulkumaran</surname><given-names>N</given-names></string-name></person-group>. <article-title>Antibiotic-induced immunosuppression&#8212;a focus on cellular immunity</article-title>. <source>Antibiot (Basel)</source>. <year>2024</year>;<volume>13</volume>(<issue>11</issue>):<fpage>1034</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antibiotics13111034</pub-id>.<pub-id pub-id-type="pmcid">PMC11591424</pub-id><pub-id pub-id-type="pmid">39596729</pub-id></mixed-citation></ref><ref id="cit0081"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Oh</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ravindran</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chassaing</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Carvalho</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Maddur</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bower</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hakimpour</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gill</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Nakaya</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yarovinsky</surname><given-names>F</given-names></string-name>, et al</person-group>. <article-title>Tlr5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination</article-title>. <source>Immunity</source>. <year>2014</year>;<volume>41</volume>(<issue>3</issue>):<fpage>478</fpage>&#8211;<lpage>492</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2014.08.009</pub-id>.<pub-id pub-id-type="pmid">25220212</pub-id><pub-id pub-id-type="pmcid">PMC4169736</pub-id></mixed-citation></ref><ref id="cit0082"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Norton</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Lynn</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Rossouw</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Abayasingam</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Perkins</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Hissaria</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Bull</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Lynn</surname><given-names>DJ</given-names></string-name></person-group>. <article-title>B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotic-treated mice</article-title>. <source>Gut</source>. <year>2024</year>;<volume>73</volume>(<issue>7</issue>):<fpage>1222</fpage>&#8211;<lpage>1224</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2023-329810</pub-id>.<pub-id pub-id-type="pmid">37500502</pub-id><pub-id pub-id-type="pmcid">PMC11185899</pub-id></mixed-citation></ref><ref id="cit0083"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lynn</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Tumes</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Choo</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Sribnaia</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Blake</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Leong</surname><given-names>LEX</given-names></string-name>, <string-name name-style="western"><surname>Young</surname><given-names>GP</given-names></string-name>, <string-name name-style="western"><surname>Marshall</surname><given-names>HS</given-names></string-name>, <string-name name-style="western"><surname>Wesselingh</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Rogers</surname><given-names>GB</given-names></string-name>, et al</person-group>. <article-title>Early-life antibiotic-driven dysbiosis leads to dysregulated vaccine immune responses in mice</article-title>. <source>Cell Host &amp; Microbe</source>. <year>2018</year>;<volume>23</volume>(<issue>5</issue>):<fpage>653</fpage>&#8211;<lpage>660.e5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2018.04.009</pub-id>.<pub-id pub-id-type="pmid">29746836</pub-id></mixed-citation></ref><ref id="cit0084"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Elvers</surname><given-names>KT</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>VJ</given-names></string-name>, <string-name name-style="western"><surname>Hammond</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Duncan</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Huntley</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Hay</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>van der Werf</surname><given-names>ET</given-names></string-name></person-group>. <article-title>Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review</article-title>. <source>BMJ Open</source>. <year>2020</year>;<volume>10</volume>(<issue>9</issue>):<fpage>e035677</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2019-035677</pub-id>.<pub-id pub-id-type="pmcid">PMC7507860</pub-id><pub-id pub-id-type="pmid">32958481</pub-id></mixed-citation></ref><ref id="cit0085"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Baldelli</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Scaldaferri</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Putignani</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Del Chierico</surname><given-names>F</given-names></string-name></person-group>. <article-title>The role of Enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases</article-title>. <source>Microorganisms</source>. <year>2021</year>;<volume>9</volume>(<issue>4</issue>):<fpage>697</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms9040697</pub-id>.<pub-id pub-id-type="pmid">33801755</pub-id><pub-id pub-id-type="pmcid">PMC8066304</pub-id></mixed-citation></ref><ref id="cit0086"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lee</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>W</given-names></string-name></person-group>. <article-title>Microbiota in T-cell homeostasis and inflammatory diseases</article-title>. <source>Exp Mol Med</source>. <year>2017</year>;<volume>49</volume>(<issue>5</issue>):<fpage>e340</fpage>. doi: <pub-id pub-id-type="doi">10.1038/emm.2017.36</pub-id>.<pub-id pub-id-type="pmid">28546563</pub-id><pub-id pub-id-type="pmcid">PMC5454441</pub-id></mixed-citation></ref><ref id="cit0087"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Franco</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chambers</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sette</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Grifoni</surname><given-names>A</given-names></string-name></person-group>. <article-title>SARS-CoV-2 spike-specific regulatory T cells (Treg) expand and develop memory in vaccine recipients suggesting a role for immune regulation in preventing severe symptoms in COVID-19</article-title>. <source>Autoimmunity</source>. <year>2023</year>;<volume>56</volume>(<issue>1</issue>):<fpage>2259133</fpage>. doi: <pub-id pub-id-type="doi">10.1080/08916934.2023.2259133</pub-id>.<pub-id pub-id-type="pmid">37724524</pub-id><pub-id pub-id-type="pmcid">PMC12167603</pub-id></mixed-citation></ref><ref id="cit0088"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Feng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>de Jong</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Oliveira</surname><given-names>APBN</given-names></string-name>, <string-name name-style="western"><surname>Samaha</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Beydoun</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, et al</person-group>. <article-title>Antibiotic-induced gut microbiome perturbation alters the immune responses to the rabies vaccine</article-title>. <source>Cell Host &amp; Microbe</source>. <year>2025</year>;<volume>33</volume>(<issue>5</issue>):<fpage>705</fpage>&#8211;<lpage>718.e5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2025.03.015</pub-id>.<pub-id pub-id-type="pmid">40252648</pub-id><pub-id pub-id-type="pmcid">PMC12084132</pub-id></mixed-citation></ref><ref id="cit0089"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nadeem</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Maurya</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Das</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Khan</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Agrewala</surname><given-names>JN</given-names></string-name></person-group>. <article-title>Gut dysbiosis thwarts the efficacy of vaccine against Mycobacterium tuberculosis</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>11</volume>:<fpage>726</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.00726</pub-id>.<pub-id pub-id-type="pmid">32508806</pub-id><pub-id pub-id-type="pmcid">PMC7248201</pub-id></mixed-citation></ref><ref id="cit0090"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hassert</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Harty</surname><given-names>JT</given-names></string-name></person-group>. <article-title>Tissue resident memory T cells- a new benchmark for the induction of vaccine-induced mucosal immunity</article-title>. <source>Front Immunol</source>. <year>2022</year>;<volume>13</volume>:<fpage>1039194</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.1039194</pub-id>.<pub-id pub-id-type="pmid">36275668</pub-id><pub-id pub-id-type="pmcid">PMC9581298</pub-id></mixed-citation></ref><ref id="cit0091"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Folign&#233;</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Daniel</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Pot</surname><given-names>B</given-names></string-name></person-group>. <article-title>Probiotics from research to market: the possibilities, risks and challenges</article-title>. <source>Curr Opin Microbiol</source>. <year>2013</year>;<volume>16</volume>(<issue>3</issue>):<fpage>284</fpage>&#8211;<lpage>292</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2013.06.008</pub-id>.<pub-id pub-id-type="pmid">23866974</pub-id></mixed-citation></ref><ref id="cit0092"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Luo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lv</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Zuo</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Ye</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ke</surname><given-names>J</given-names></string-name></person-group>. <article-title>Influenza and the gut microbiota: a hidden therapeutic link</article-title>. <source>Heliyon</source>. <year>2024</year>;<volume>10</volume>(<issue>18</issue>):<fpage>e37661</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e37661</pub-id>.<pub-id pub-id-type="pmid">39315196</pub-id><pub-id pub-id-type="pmcid">PMC11417228</pub-id></mixed-citation></ref><ref id="cit0093"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Roller</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rechkemmer</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Watzl</surname><given-names>B</given-names></string-name></person-group>. <article-title>Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats</article-title>. <source>J Sport Hist Of Nutrition</source>. <year>2004</year>;<volume>134</volume>(<issue>1</issue>):<fpage>153</fpage>&#8211;<lpage>156</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jn/134.1.153</pub-id>.<pub-id pub-id-type="pmid">14704309</pub-id></mixed-citation></ref><ref id="cit0094"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Swanson</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Grieshop</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Flickinger</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Merchen</surname><given-names>NR</given-names></string-name>, <string-name name-style="western"><surname>Fahey</surname><given-names>GC</given-names></string-name></person-group>. <article-title>Effects of supplemental fructooligosaccharides and mannanoligosaccharides on colonic microbial populations, immune function and fecal odor components in the canine</article-title>. <source>J Sport Hist Of Nutrition</source>. <year>2002</year>;<volume>132</volume>(<issue>6</issue>):<fpage>1717S</fpage>&#8211;<lpage>1719S</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jn/132.6.1717S</pub-id>.<pub-id pub-id-type="pmid">12042505</pub-id></mixed-citation></ref><ref id="cit0095"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Manhart</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Spittler</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bergmeister</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Mittlb&#246;ck</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Roth</surname><given-names>E</given-names></string-name></person-group>. <article-title>Influence of fructooligosaccharides on Peyer&#8217;s patch lymphocyte numbers in healthy and endotoxemic mice</article-title>. <source>Nutrition</source>. <year>2003</year>;<volume>19</volume>(<issue>7&#8211;8</issue>):<fpage>657</fpage>&#8211;<lpage>660</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0899-9007(03)00059-5</pub-id>.<pub-id pub-id-type="pmid">12831954</pub-id></mixed-citation></ref><ref id="cit0096"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zeng</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name></person-group>. <article-title>The role of probiotics in coronavirus disease-19 infection in Wuhan: a retrospective study of 311 severe patients</article-title>. <source>Int Immunopharmacol</source>. <year>2021</year>;<volume>95</volume>:<fpage>107531</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.intimp.2021.107531</pub-id>.<pub-id pub-id-type="pmid">33714884</pub-id><pub-id pub-id-type="pmcid">PMC7934664</pub-id></mixed-citation></ref><ref id="cit0097"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rizzardini</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Eskesen</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Calder</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>Capetti</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jespersen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Clerici</surname><given-names>M</given-names></string-name></person-group>. <article-title>Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12 &#174; and Lactobacillus paracasei ssp. paracasei, L. casei 431 &#174; in an influenza vaccination model: a randomised, double-blind, placebo-controlled study</article-title>. <source>Br J Nutr</source>. <year>2012</year>;<volume>107</volume>(<issue>6</issue>):<fpage>876</fpage>&#8211;<lpage>884</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S000711451100420X</pub-id>.<pub-id pub-id-type="pmid">21899798</pub-id></mixed-citation></ref><ref id="cit0098"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boge</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>R&#233;migy</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Vaudaine</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tanguy</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Bourdet-Sicard</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>van der Werf</surname><given-names>S</given-names></string-name></person-group>. <article-title>A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials</article-title>. <source>Vaccine</source>. <year>2009</year>;<volume>27</volume>(<issue>41</issue>):<fpage>5677</fpage>&#8211;<lpage>5684</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.06.094</pub-id>.<pub-id pub-id-type="pmid">19615959</pub-id></mixed-citation></ref><ref id="cit0099"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Arioz Tunc</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Childs</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Swann</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Calder</surname><given-names>PC</given-names></string-name></person-group>. <article-title>The effect of oral probiotics on response to vaccination in older adults: a systematic review of randomised controlled trials</article-title>. <source>Age And Ageing</source>. <year>2024</year>;<volume>53</volume>(<issue>Supplement_2</issue>):<fpage>ii70</fpage>&#8211;<lpage>ii79</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ageing/afae033</pub-id>.<pub-id pub-id-type="pmid">38745493</pub-id></mixed-citation></ref><ref id="cit0100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yeh</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Shih</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Lei</surname><given-names>WT</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>C-Y</given-names></string-name></person-group>. <article-title>The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials the influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Drug Des Devel Ther</source>. <year>2018</year>;<volume>12</volume>:<fpage>217</fpage>&#8211;<lpage>230</lpage>. <ext-link xlink:href="https://doaj.org/article/c3ab2b2414aa4da5b8b6690e5162285b" ext-link-type="uri">https://doaj.org/article/c3ab2b2414aa4da5b8b6690e5162285b</ext-link>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/DDDT.S155110</pub-id><pub-id pub-id-type="pmcid">PMC5790137</pub-id><pub-id pub-id-type="pmid">29416317</pub-id></mixed-citation></ref><ref id="cit0101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kullar</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Goldstein</surname><given-names>EJC</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>McFarland</surname><given-names>LV</given-names></string-name></person-group>. <article-title>Lactobacillus bacteremia and probiotics: a review</article-title>. <source>Microorganisms</source>. <year>2023</year>;<volume>11</volume>(<issue>4</issue>):<fpage>896</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms11040896</pub-id>.<pub-id pub-id-type="pmid">37110319</pub-id><pub-id pub-id-type="pmcid">PMC10145752</pub-id></mixed-citation></ref><ref id="cit0102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wischmeyer</surname><given-names>PE</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Bohannon</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Bergens</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ramirez</surname><given-names>ZE</given-names></string-name>, <string-name name-style="western"><surname>Andermann</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Messina</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Sung</surname><given-names>JA</given-names></string-name>, et al</person-group>. <article-title>Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: a double-blind, placebo-controlled randomized trial</article-title>. <source>Clin Nutr (Edinburgh, Scotl)</source>. <year>2024</year>;<volume>43</volume>(<issue>1</issue>):<fpage>259</fpage>&#8211;<lpage>267</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2023.11.043</pub-id>.<pub-id pub-id-type="pmid">38103462</pub-id></mixed-citation></ref><ref id="cit0103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lau</surname><given-names>RI</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Lau</surname><given-names>ISF</given-names></string-name>, <string-name name-style="western"><surname>Ching</surname><given-names>JYL</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>MCS</given-names></string-name>, <string-name name-style="western"><surname>Lau</surname><given-names>LHS</given-names></string-name>, <string-name name-style="western"><surname>Tun</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Mok</surname><given-names>CKP</given-names></string-name>, <string-name name-style="western"><surname>Chau</surname><given-names>SWH</given-names></string-name>, <string-name name-style="western"><surname>Tse</surname><given-names>YK</given-names></string-name>, et al</person-group>. <article-title>A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial</article-title>. <source>Lancet Infect Dis</source>. <year>2024</year>;<volume>24</volume>(<issue>3</issue>):<fpage>256</fpage>&#8211;<lpage>265</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(23)00685-0</pub-id>.<pub-id pub-id-type="pmid">38071990</pub-id></mixed-citation></ref><ref id="cit0104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Guti&#233;rrez-Castrell&#243;n</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gandara-Mart&#237;</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Abreu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Abreu</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Nieto-Rufino</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>L&#243;pez-Ordu&#241;a</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Jim&#233;nez-Escobar</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>L&#243;pez-Velazquez</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Espadaler-Mazo</surname><given-names>J</given-names></string-name></person-group>. <article-title>Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial</article-title>. <source>Gut Microbes</source>. <year>2022</year>;<volume>14</volume>(<issue>1</issue>):<fpage>2018899</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2021.2018899</pub-id>.<pub-id pub-id-type="pmid">35014600</pub-id><pub-id pub-id-type="pmcid">PMC8757475</pub-id></mixed-citation></ref><ref id="cit0105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jespersen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Tarnow</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Eskesen</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Morberg</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Michelsen</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Bugel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dragsted</surname><given-names>LO</given-names></string-name>, <string-name name-style="western"><surname>Rijkers</surname><given-names>GT</given-names></string-name>, <string-name name-style="western"><surname>Calder</surname><given-names>PC</given-names></string-name></person-group>. <article-title>Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study</article-title>. <source>Am J Clin Nutr</source>. <year>2015</year>;<volume>101</volume>(<issue>6</issue>):<fpage>1188</fpage>&#8211;<lpage>1196</lpage>. doi: <pub-id pub-id-type="doi">10.3945/ajcn.114.103531</pub-id>.<pub-id pub-id-type="pmid">25926507</pub-id></mixed-citation></ref><ref id="cit0106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bosch</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>M&#233;ndez</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>P&#233;rez</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Farran</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Fuentes</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Cu&#241;&#233;</surname><given-names>J</given-names></string-name></person-group>. <article-title>Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly Lactobacillus plantarum CECT7315 y CECT7316 estimula la producci&#243;n de inmunoglobulinas tras la vacunaci&#243;n contra la influenza en ancianos</article-title>. <source>Nutrici&#243;n Hospitalaria : Organo Oficial de la Soc Espa&#241;ola de Nutrici&#243;n Parenteral y Enter</source>. <year>2012</year>;<volume>27</volume>(<issue>2</issue>):<fpage>504</fpage>&#8211;<lpage>509</lpage>. <ext-link xlink:href="https://doaj.org/article/776b1bec212d4614b19e55734c7d6c24" ext-link-type="uri">https://doaj.org/article/776b1bec212d4614b19e55734c7d6c24</ext-link>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/S0212-16112012000200023</pub-id><pub-id pub-id-type="pmid">22732975</pub-id></mixed-citation></ref><ref id="cit0107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Davidson</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Fiorino</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Snydman</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Hibberd</surname><given-names>PL</given-names></string-name></person-group>. <article-title>Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial</article-title>. <source>Eur J Clin Nutr</source>. <year>2011</year>;<volume>65</volume>(<issue>4</issue>):<fpage>501</fpage>&#8211;<lpage>507</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ejcn.2010.289</pub-id>.<pub-id pub-id-type="pmid">21285968</pub-id><pub-id pub-id-type="pmcid">PMC3071884</pub-id></mixed-citation></ref><ref id="cit0108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Licciardi</surname><given-names>PV</given-names></string-name>, <string-name name-style="western"><surname>Ismail</surname><given-names>IH</given-names></string-name>, <string-name name-style="western"><surname>Balloch</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mui</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hoe</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Lamb</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>MLK</given-names></string-name></person-group>. <article-title>Maternal supplementation with LGG reduces vaccine-specific immune responses in infants at high-risk of developing allergic disease</article-title>. <source>Front Immunol</source>. <year>2013</year>;<volume>4</volume>:<fpage>381</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2013.00381</pub-id>.<pub-id pub-id-type="pmid">24324465</pub-id><pub-id pub-id-type="pmcid">PMC3840393</pub-id></mixed-citation></ref><ref id="cit0109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wong</surname><given-names>MCS</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Ching</surname><given-names>JYL</given-names></string-name>, <string-name name-style="western"><surname>Mak</surname><given-names>JWY</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mok</surname><given-names>CKP</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chiu</surname><given-names>O-L</given-names></string-name>, <string-name name-style="western"><surname>Fung</surname><given-names>Y-T</given-names></string-name>, et al</person-group>. <article-title>Effects of gut microbiome modulation on reducing adverse health outcomes among elderly and diabetes patients during the COVID-19 pandemic: a randomised, double-blind, placebo-controlled trial (IMPACT study)</article-title>. <source>Nutrients</source>. <year>2023</year>;<volume>15</volume>(<issue>8</issue>):<fpage>1982</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu15081982</pub-id>.<pub-id pub-id-type="pmid">37111201</pub-id><pub-id pub-id-type="pmcid">PMC10143994</pub-id></mixed-citation></ref><ref id="cit0110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ngo</surname><given-names>VL</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Britton</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Zou</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ramani</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Gewirtz</surname><given-names>AT</given-names></string-name></person-group>. <article-title>Select gut microbiota impede rotavirus vaccine efficacy</article-title>. <source>Cellular Mol Gastroenterol Hepatol</source>. <year>2024</year>;<volume>18</volume>(<issue>5</issue>):<fpage>101393</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcmgh.2024.101393</pub-id>.<pub-id pub-id-type="pmcid">PMC11462264</pub-id><pub-id pub-id-type="pmid">39179176</pub-id></mixed-citation></ref><ref id="cit0111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wynn</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Beyer</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Richards</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ennis</surname><given-names>LA</given-names></string-name></person-group>. <article-title>Procedure, screening, and cost of fecal microbiota transplantation</article-title>. <source>Cureus</source>. <year>2023</year>;<volume>15</volume>(<issue>2</issue>):<fpage>e35116</fpage>. doi: <pub-id pub-id-type="doi">10.7759/cureus.35116</pub-id>.<pub-id pub-id-type="pmid">36938236</pub-id><pub-id pub-id-type="pmcid">PMC10023044</pub-id></mixed-citation></ref><ref id="cit0112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Merrick</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Allen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Masirah</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Forbes</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Shawcross</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Goldenberg</surname><given-names>SD</given-names></string-name></person-group>. <article-title>Regulation, risk and safety of faecal microbiota transplant</article-title>. <source>Infect Prev Pract</source>. <year>2020</year>;<volume>2</volume>(<issue>3</issue>):<fpage>100069</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.infpip.2020.100069</pub-id>.<pub-id pub-id-type="pmid">34316559</pub-id><pub-id pub-id-type="pmcid">PMC7280140</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>